{
  "name" : "_cyber.sci-hub.se_MTAuMTAxNi9qLm1zZWMuMjAxNy4wMy4xOTY=_zhang2017.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Advanced review of graphene-based nanomaterials in drug delivery systems: Synthesis, modification, toxicity and application",
    "authors" : [ "Qi Zhang", "Zhuona Wu", "Ning Li", "Yiqiong Pu", "Bing Wang", "Tong Zhang", "Jiansheng Tao" ],
    "emails" : [ "annabel_cn@163.com", "zhangtdmj@hotmail.com", "taojs@sohu.com" ],
    "sections" : [ {
      "heading" : null,
      "text" : "AC C\nEP TE\nD M\nThe discovery of graphene, a notable achievement in the field of novel carbon nanomaterials, has triggered the worldwide exploration of the biomedical applications of this material since 2004 because of its unique properties. The two-dimensional planar structure, large surface area, chemical stability, mechanical stability, and good biocompatibility of graphene are promising for applications in drug delivery systems (DDSs). In this review, we briefly discuss the characteristics, synthesis, and modification of graphene. We also investigate its toxicity and its applications in DDSs, with several representative examples. This review presents a comprehensive summary of graphene-based nanomaterials from their characteristics to their synthesis and applications, as well as their in vitro and in vivo evaluation in medicine. This paper provides a guiding strategy for the selection of optimal approaches to the fabrication of nanocarriers that are suitable for medical treatments and to\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\ncontrolling the toxicity within therapeutic safety limits. The promising achievements made with graphene-based nanomaterials indicate several possibilities for further biomedical research, as well as theoretical and applied development. Keywords: graphene, nanomaterials, modification, drug delivery system, toxicity"
    }, {
      "heading" : "1. Introduction",
      "text" : "Carbon is one of the most abundant elements in nature; carbon atoms can form complicated\nnetworks that are fundamental to organic chemistry and the existence of life [1]. Carbon is a unique material that can exist in forms that range from zero-dimensional (0-D) to three-dimensional (3-D) [2]. In addition, allotropes of carbon have various properties, from hard (diamond) to soft (graphite), from insulative (diamond) to semi-conductive (graphite) and conductive (graphene), and from light absorbing (graphite) to diaphanous (diamond) [3-5].\nGraphite and its allotropes, such as graphene, graphene oxide (GO), carbon nanotubes (CNTs),\nand reduced graphene oxide (RGO), have attracted extensive interest for use in quantum physics [6], nanoelectronics [4, 7], catalysis [8], nanocomposites [9], and sensor technology [10] because of their unique structure and geometry. Graphite and its allotropes possess outstanding physicochemical properties, including high fracture strength and Young’s modulus, excellent electrical and thermal conductivity, quick charge carrier mobility, large specific surface area, and good biocompatibility [11-14] and have thus been widely used in medical science and biotechnology, including in sensitive biosensors [15], drug delivery systems (DDSs) [16], and near-infrared (NIR) fluorescence imaging techniques [17-19].\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nFig. 1. Common structure of all graphitic forms, which can be changed into 0-D fullerence, 1-D nanotubes, and 3-D graphite. (Ref. 21) (Adapted from Nat. Mater. 2007,(61): 183-191, with permission from Nature Publishing Group)\nThe allotropes of carbon have various structures and properties but share a common\ntwo-dimensional (2-D) structure called graphene, which was first prepared in 2004 [20]. Graphene can be transformed into spherical structures (0-D fullerenes), tubulate structures (one-dimensional carbon nanotubes, 1-D CNTs) or layered structures (3-D graphite) (Fig. 1) [21]. The free-standing 2-D crystal of graphene is composed of six-atom rings in a honeycombed network with one-atom thickness; thus, graphene can function as a planar aromatic macromolecule [22], which results in several unique properties. Since a single layer of graphene was first prepared in 2004 using a sticky tape and a pencil [20], several efficient production methods for graphene have been developed, such as micromechanical exfoliation, chemical vapor deposition (CVD), epitaxial growth, and chemical synthesis [23]. In addition, GO can be mass produced with high throughput, low processing cost, and feasible chemical functionalization;[9] thus, graphene can be obtained in large quantities via the reduction of GO [24].\nCompared with other carbon allotropes, such as CNTs, graphene has several advantages in\nvarious applications, including biosensors (including DNA [25], antibodies [26], saccharides [27], inorganic constituents [28], drug molecules [29, 30], and multicomponent [31] determination) and drug delivery, because of its lower toxicity and superior biocompatibility [32]. Though biosensors\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nhave been widely explored, the application in drug delivery has been increasing in recent years. For example, because of its high specific surface area [33], the drug loading ratio of graphene nanomaterials is considerably higher than those of other DDSs [34, 35]. With the exist of GO, elastic modulus and tensile strength of nanofibers have been enhanced dramatically [36]. Moreover, Dai et al. first discovered that polyethylene glycol (PEG)-functionalized GO can be used as a novel drug nanocarrier to load anti-cancer drugs via non-covalent physisorption with in vitro cellular uptake capacity [37, 38]. Thus, graphene family nanomaterials (GFNs) have been widely explored as drug carriers in recent years.\nIn this review, we first discuss the unique properties of graphene and the methods of synthesis\nand modification. Second, we illustrate the toxicity of graphene at the microbial, cellular, and animal levels. We also introduce several examples of the latest advances in drug delivery applications, including targeting, controlled and multifunctional DDSs, to reflect the advantages of modified GO. Finally, we conclude this review and provide a prospective outlook on the further development of graphene."
    }, {
      "heading" : "2. Characteristics of Graphene",
      "text" : "As a basic component of other carbon allotropes, graphene has a 2-D structure composed of\nsix-atom rings in a honeycomb network with one-atom thickness [22]. Each carbon atom is bonded to three other carbon atoms. The C–C bond length is 1.42 Å, with a bond angle of 120°. Each carbon atom forms three σ-bonds via three sp 2 hybrid orbitals with three carbon atoms; the rest of the p-orbital forms a conjugated system with other contiguous carbon atoms. In this conjugated system, each carbon atom provides a p-electron; thus, the carbon skeleton of graphene is made of σ-bonds with paired electron clouds above and below the skeleton. The bonding form is identical to that in the benzene structure; thus, graphene could be regarded as an enormous polycyclic aromatic hydrocarbon (PAH).\nThe special structure of graphene allows for unique properties. Table 1 lists the physical\nproperties of graphene [39]. Graphene has a structure similar to that of a PAH; thus, graphene\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nprobably possesses the properties of graphite and PAHs. These unique properties could be used in several fields [40, 41]. For example, good light absorption in the visible and infrared regions causes the low saturation of graphene; thus, graphene could be designed as a laser switch or photonic crystal. The combination of high thermal conductivity with high stability and charge mobility could enable graphene to be used in microthermal electrical components. Graphene could also be applied in micropressure sensors or resonators because of its high spring constant (1–5 N m -1 ) and Young’s modulus.\nTable 1. Summary of graphene properties. (Ref. 39)\nProperties Value Observations Length of the lattice vector aC-C≈1.42Å is the carbon bond length Surface area 2600 m2 g-1 Theoretical prediction Mobility 15000 cm2 V-1 s-1 (typical)\n200000 cm2 V-1 s-1 (intrinsic) Room temperature\nMeans free path (ballistic transport) 300–500 nm Room temperature Fermi velocity c/300=1000 000 m s-1 Room temperature Electron effective mass 0.06 mo Room temperature Hole effective mass 0.03 mo Room temperature Thermal conductivity (5.3±0.48)×103 W m-1 K-1 Better thermal conductivity than in most crystals Breaking strength 40 N m-1 Reaching theoretical limit Young’s modulus 1.0 TPa Ten times greater than in steel Opacity 2.3% Visible light Optical transparency 97.9% Visible light"
    }, {
      "heading" : "3. Synthesis of Graphene",
      "text" : "Researchers have recently targeted the large-scale fabrication of perfect graphene and GO. In\ngeneral, the preparation methods can be classified into two categories: top-down organic synthetic approaches and bottom-up organic synthetic approaches [42]. Top-down approaches, such as mechanical cleavage, the redox method, and arc discharge, utilize natural graphite as the carbon source and yield single- or few-layered graphene and GO through physical or chemical exfoliation\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nor shear. Bottom-up approaches, such as CVD and organic synthesis, utilize small carbon compounds to synthesize large single- or few-layered graphene and GO. We also discuss other synthetic approaches in this review. 3.1. Top-Down Organic Synthetic Approaches\nFor top-down approaches, we introduce mechanical cleavage, the redox method, and arc\ndischarge (Fig. 2). Mechanical cleavage is the earliest reported approach for synthesizing graphene. In 2004, Novoselov et al. [20] first fabricated and observed single-layered graphene by exfoliating highly oriented pyrolytic graphite. This approach was later simplified by repeatedly pasting the graphite [21].\nFig. 2. Top-down organic synthetic approaches.\nThe redox method is one of the most common approaches for fabricating graphene and GO. This\napproach utilizes a strong acid to react with graphite before an oxidizing agent is added to destroy the crystal structure of graphite and introduce oxygen-containing functional groups to form GO. Finally, GO is reduced to obtain graphene. This approach was proposed in 1859 by Brodie et al.\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\n[43], who utilized fuming nitric acid as the solvent and KClO3 as the oxidizing agent to oxidize graphite. Staudenmaier et al. [44] proposed another approach for oxidization, and Schniepp et al. [45] improved this approach. In this alternative approach, concentrated sulfuric acid and nitric acid are used as solvents, and KClO3 is used as the oxidizing agent to oxidize graphite before a final wash with diluted hydrochloric acid and water, respectively. The most popular approach for fabricating graphene and GO is the Hummers method [46]. In this method, GO is obtained by adding graphite and NaNO3 to concentrated sulfuric acid, followed by KMnO4 as the oxidizing agent to oxidize the graphite; 30% H2O2 is then added to reduce the remnant oxidizing agent and obtain GO.\nArc discharge is another approach to the large-scale preparation of graphene and GO. In this\nmethod, a certain amount of electric current is applied to two graphite electrodes at a certain pressure of buffer gas; when the arc discharges, the anode is consumed, and graphene is obtained on the cathode. Using this approach, the obtained graphene has a high crystallization degree with few defects, high electrical conductivity, and great thermal stability and can be fabricated on a large scale. Subrahmanyam et al. [47] developed an arc discharge method to fabricate graphene using hydrogen and helium as the buffer gas. Hydrogen is essential for the synthesis of graphene because it can react with the active carbon atoms at the edge of graphene, which stops graphene from tucking into the sealing structure of the ring. 3.2. Bottom-Up Organic Synthetic Approaches\nBottom-up approaches start with a small aromatic molecule and yield a PAH, which is also called\nnanographene, via several organic synthetic methods. To date, bottom-up approaches remain essential for fabricating graphene in high performance and high yield. The most typical method is based on the cyclodehydrogenation of polyphenylene dendrimers [48]. Fig. 3 shows the synthesis of a PAH by cyclodehydrogenation [49]. Ruoff and his group studied acetylenic coupling [50] and alkyne metathesis reactions [51, 52] with isomerization as another type of bottom-up organic synthesis.\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nFig. 3. Cyclodehydrogenation of polyphenylene dendrimers. (Ref. 49)\nCVD is an efficient method for fabricating graphene. A plane base consisting of a metal film,\nsingle metal crystals, or polycrystals that can degrade at high temperatures is placed in a precursor gas, such as methane or ethane; graphene is obtained on the surface of the base by high-temperature annealing. CVD can be classified as thermal CVD and plasma-enhanced CVD. The first thermal CVD method was reported by Somani et al. [53] in 2006. Their group utilized camphor as a carbon source, which was heated to 180 °C; argon was used to carry the degraded camphor to the CVD stove with nickel plates. When the CVD stove had cooled to room temperature, several layers of graphene were formed on the nickel plates. The earliest research on plasma-enhanced CVD was conducted in 2004 [54]. For plasma-enhanced CVD, a special surface treatment or metal catalyst is not necessary; using this simple method, researchers could obtain purer graphene. 3.3. Other Synthetic Approaches\nSiC epitaxial growth utilizes an ultra-high vacuum and high temperatures to remove Si from SiC\nbefore graphene is obtained from the reconstruction of the carbon atoms. Heer et al. summarized the variations of this method and reported that graphene with large sizes, high quality, and good prospective applications could be fabricated using the integrated circuit technique [55].\nCO reduction was proposed by Kim et al. [56]. Their group selected CO as a carbon source and\nutilized direct reduction to fabricate graphene sheets by calcinating aluminum sulfide (Al2S3) under a mixed gas containing CO and argon at 1300 °C. The corresponding reaction equations are as follows:\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "4. Modification of Graphene",
      "text" : "Graphene is highly hydrophobic because of the lack of oxygen-containing hydrophilic groups. The π–π stacking interactions cause the strong combination of graphene layers, which has crucial implications for its dispersion in water. GO has oxygen-containing hydrophilic groups on its surfaces as well as defects, but this compound still aggregates in the presence of salts because of the charge screening effect [57]. Aggregation negatively impacts the applications of GO, such as in medicine, materials, and sensors. Therefore, the modification of graphene and GO is necessary.\nTo improve the deficiencies in the nature of graphene and GO, researchers usually introduce\nactive functional groups that improve the dispersion in water and offer new optical, electric, and magnetic properties, among others [58]. 4.1. Covalent Modifications\nCovalent modification is one of the most extensive methods for graphene and GO\nfunctionalization, wherein active double bonds and oxygen-containing groups are usually introduced. The main approach to the modification of graphene is through GO, the precursor of graphene; the abundant hydroxy, carboxyl, and epoxy groups can be used for covalent modifications, whereas the defects and edges have high reactivity [59, 60]; thus, these components can be used for the modification of graphene and GO.\nStankovich et al. [61] first modified GO using a covalent method in 2006. Isocyanates were\nreacted with the hydroxyl and carboxyl groups of synthetic GO, and a series of isocyanate-treated graphite oxides (iGOs) were obtained. These iGOs could be homogeneously and stably dispersed in different types of polar aprotic solvents, such as N,N-dimethylformamide (DMF). Therefore, this simplified, temperate, and efficient method represents a novel approach for further processing and applications. Other researchers, such as Golestanzadeh et al. [62], Yazid et al. [63], Kazemi et al. [64], and Ren et al. [65], also utilized the hydroxyl and carboxyl groups to modify GO.\nAmidation is an efficient covalent modification method. Travlou et al. [66] utilized the amino\nAC C\nEP TE\nD\nM\ngroups of magnetic chitosan (CS) to modify GO and obtained the novel nanocomposite material, GO−CS (Fig. 4), which could homogeneously and spontaneously absorb a reactive dye (Reactive Black 5). Other polymers, such as PEG [37, 38, 67], poly(vinyl alcohol) (PVA) [68], polyethylenimine (PEI) [69], sodium alginate [70], and amphiphilic copolymers [71], have also been grafted onto graphene or GO sheets via covalent methods to improve their properties, such as increasing their stability, hydrophilicity, and cellular uptake or decreasing their cytotoxicity.\nMoreover, epoxy groups can serve as the reaction points for modification. Ma et al. covalently\nmodified 3 nm-thick graphene platelets (GnPs) by reacting the epoxy groups of GnPs with the end-amine groups of a commercial long-chain surfactant (Mw = 2000); the GnP thickness inevitably increased to 5 nm. However, the stiffness, fracture toughness, and electrical conductivity were much higher than those in the unmodified nanocomposites, and the Young’s modulus, fracture energy release rate, and glass transition temperature were increased by 14%, 387%, and 13%, respectively [72].\nThe free radical reaction is another method of covalent modification. Beckert et al. [73] exploited\nthe solvent-free free radical grafting of styrene homopolymers and copolymers onto functionalized graphene nanosheets without the addition of an initiator. By covalently attaching polymer chains to functional graphene nanosheets, the dispersibility of graphene was greatly improved, regardless of\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nwhether the molecular weight was low or high or the organic media was polar or nonpolar. Furthermore, the melt rheology of the composite in a polystyrene matrix revealed the unique time-dependent behavior of the formed graphene particle network, and the electrical conductivity was substantially improved.\nOther researchers have identified materials, such as ionic liquids, with unique structures and\nproperties that can be used for covalent modification. Chaiyo et al. [74] designed a simple, low-cost, and highly sensitive electrochemical sensor by utilizing a Nafion/ionic liquid/graphene composite-modified screen-printed carbon electrode. The modified electrode exhibited greatly improved stripping performance in the determination of Zn, Cd, and Pb, and a new type of sensor based on this electrode had significantly lower detection limits of 0.09, 0.06, and 0.08 ng L -1 , respectively.\nOther methods are also available for covalent modifications. For example, Che et al. [75]\nexploited a simple one-step reaction that simultaneously modifies and reduces GO. The obtained modified graphene nanosheets satisfied anti-static requirements while homogeneously dispersing in an organic solvent, which is beneficial to subsequent operations. 4.2. Non-Covalent Modifications\nNon-covalent modification can adequately maintain the structures and properties of graphene.\nVan der Waals forces, ionic bonds, hydrogen bonding, coordination bonds, and π–π stacking interactions have been extensively used to modify graphene and GO; the first non-covalent modification of GO was reported by Stankovich et al. [76], who utilized poly(sodium 4-styrenesulfonate) (PSS) to modify GO, which was reduced via exfoliation or in situ reduction. The strong non-covalent interaction between PSS and graphene prevents the graphene sheets from aggregating.\nUtilizing π–π stacking interactions is the most efficient method of non-covalent modification.\nYang et al. [77] constructed a nanosupramolecular assembly through the non-covalent linkage of folic acid (FA)-modified β-cyclodextrin and GO with adamantane-grafted porphyrin via π–π\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nstacking (Fig. 5). Wang et al. [78] probed the potential adsorptive sites and molecular mechanisms of the adsorption of naphthalene, phenanthrene, and pyrene onto graphene and GO; the delocalized π-electron system was evaluated in terms of the adsorption of organic molecules. Otherwise, Azadbakht et al. [79] utilized π–π stacking interactions to load Au nanoparticles on GO. Above all, π–π stacking interactions could not only adsorb organic component, but also inorganic component.\nFig. 5. π–π stacking interaction to synthesize 1/2/DOX/GO multiple supramolecular. (Ref. 77)\nIonic interactions represent another common method of non-covalent modification. Although GO has good solubility in water, RGO, which is synthesized by physical or chemical reduction, tends to aggregate and cannot be redisposed. Wang et al. [80] developed a new approach for graphene assembly. First, GO and tetrabutylammonium (TBA) were dispersed by ultrasonication; after 2 days, the supernatant was mixed with phospholipid-polyethylene glycol-amine (PL–PEG-NH2) and ultrasonicated before the black homogeneous supernatant was separated by centrifugation. Finally, the complex, which was fabricated by electroplating Au onto a Si/SiO2 semi-conductor by electron-beam lithography, was immersed in the black homogeneous supernatant to obtain\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nfunctionalized graphene sheets that self-assembled onto patterned gold structures.\nHydrogen bonds are strong non-covalent bonds; hydroxyl, carboxyl and other polar groups on\nGO can easily combine with other materials through hydrogen bonding. This reliable method produces no impurities. For example, Compton et al. [81] and Wang et al. [82] have reported polymer–GO nanocomposites associated by hydrogen bonds. In addition, van der Waals forces can be used in the non-covalent modification of graphene and GO [83].\nNon-covalent modification has several advantages, but the adsorption of materials onto the\ngraphene and GO surface is not as strong as the bonding in covalent modification; if the external environment changes, the complex would become unstable for the former case. Zhang et al. [84] compared the effectiveness of drugs loaded on PEI–GO that had been prepared using (a) a non-covalent adsorption method and (b) a covalent method and found that the carrier produced using method a was not as stable as that produced using method b."
    }, {
      "heading" : "5. Toxicity of Graphene",
      "text" : "GFNs are not devoid of risks to human health. Therefore, prior to any prospective medical\napplications, a more thorough comprehension of the toxicological profile of GFNs is required. We discuss the potential risk factors of GFNs at the cellular, microbial, and in vivo level and illustrate several approaches to reduce their toxicity. 5.1. Microbial Studies\nThe toxicity of GFNs to microorganisms is important for antimicrobial products in environmental\nand clinical applications. Liu et al. [85] compared the antibacterial activity of graphite, graphite oxide, GO, and RGO under similar conditions and found that GO had the strongest antibacterial activity. Other groups have evaluated the antibacterial activity of Gram-negative and Gram-positive bacteria. GO inhibited Gram-positive bacteria more effectively than Gram-negative bacteria [86], whereas some Gram-negative bacteria, such as E. coli, were resistant to GO [87]. However, when the concentration of graphene-based nanomaterials was increased (to 1 mg mL -1 ), even graphene effectively inhibited the growth of Gram-negative E. coli and Gram-positive Bacillus subtilis [88].\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nMoreover, GO and RGO exhibited antibacterial activity against certain Gram-negative bacteria, such as Pseudomonas aeruginosa [89]. In another study, Xanthomonas oryzae pv. oryzae, a representative phytopathogenic bacteria that infects rice, was utilized to assess the antibacterial activity of RGO and GO; compared with RGO and the bactericide bismerthiazol, GO showed superior bactericidal effects because of its extremely sharp edges and generation of reactive oxygen species (ROS) [90].\nGiven the unusual antibacterial activity of GO, the synergistic effect of GO and Ag can be\nutilized to fabricate antimicrobial products. To date, several antimicrobial products have been formulated [91-93]. The following mechanisms explain the antibacterial activity of Ag-modified GO materials. First, GO adheres to E. coli through hydrogen bonds between the lipopolysaccharides of the bacteria and the oxygen-containing functional groups of GO [91]. Second, GO decreases the intake of nutrition from the surroundings while increasing the interaction between Ag and the bacteria [91]. Ag can also disrupt the bacterial membrane, thereby inhibiting the respiration and replication of bacteria, which eventually leads to cell death [93]. Third, the Ag-modified GO exerts its antibacterial effect via a “capturing-killing process”, which increases the deposition of bacteria, as well as the contact between the cells and Ag-modified GO nanoparticles [92].\nFurthermore, GFNs have antifungal activity. Sawangphruk et al. [94] tested the antifungal\nactivity of RGO using three fungal species (Aspergillus niger, Aspergillus oryzae, and Fusarium oxysporum). The IC50 values of F. oxysporum, A. niger and A. oryzae were 50, 100, and 100 μg mL -1 , respectively. The inhibition of mycelial growth in the fungi was probably caused by the sharp edges of RGO. 5.2. Cellular Studies.\nThe nanosafety and nanotoxicity of CNTs have been widely investigated, but evidence of the\nbiosafety of graphene is limited. Nevertheless, some researches indicated GNFs coating materials can promote performance of some cell lines [95], several essential studies have investigated the cytotoxicity and apoptosis caused by GFNs in different cell lines.\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nGFNs can destroy the biological structures of cells. For instance, graphene induced mitochondrial\ninjury in PC12 cells in a dose- and shape-dependent manner [96] and caused plasma membrane damage in Hep G2 cells in a dose- and time-dependent manner [97], and RGO led to DNA fragmentation and chromosomal aberrations in human mesenchymal stem cells in a size- and concentration-dependent manner [98].\nFurthermore, GFNs cause side effects in normal cells. Li et al. [99] explored the biological\neffects of graphene in murine RAW 264.7 macrophages, which is one of the crucial effector cells of the innate immune system. According to their study, graphene destroys the mitochondrial membrane potential (MMP) and increases intracellular ROS to cause cytotoxicity. Subsequently, graphene causes apoptosis by inducing mitogen-activated protein kinases and the transforming growth factor-β-related signaling pathways. In addition, Liao et al. [100] explored the blood compatibility of GFNs via the hemoglobin efflux from suspended red blood cells and investigated the cytotoxicity of GFNs via the mitochondrial activity of human skin fibroblasts in the water-soluble tetrazolium salt (WST-8) assay. All of the graphene derivatives exhibited dose-dependent hemolytic activity; the aggregated graphene particles had greater cytotoxicity than the reversibly aggregated GO.\nGraphene-related cytotoxicity also affects tumor cells. Chowdhury et al. [101] evaluated the\ntoxicity of graphene derivatives in contact with four cell lines (HeLa, MCF-7, SKBR3, and NIH3T3). Six biochemical assays were used to assess the lactate dehydrogenase release, cellular metabolism, lysosomal integrity, and cell proliferation. The GFNs exerted dose-dependent, time-dependent, and differential cytotoxic effects on the four cell lines. Other studies have also reported the dose-dependent toxicity of GO and RGO on glioma cell lines [102], and GO caused dose-dependent membrane leakage and oxidative stress in ovarian cancer cells [103] and MCF-7 cells [104].\nThe genotoxicity of graphene-based materials should be explored given the close correlation\nbetween DNA damage and mutation with cancer [105]. Akhavan et al. [98] discovered that RGO nanoplatelets exerted genotoxic effects on human mesenchymal stem cells via DNA fragmentation\nAC C\nEP TE\nD M\nAN\nU\nSC R\nIP T\nand chromosomal aberrations, even at a low concentration (0.1 μg mL -1 ) if the average lateral dimension was 11±4 nm. Qiao et al. [106] compared the genotoxicity of graphene-based biomaterials with those of SiO2, ZnO, TiO2, and Sn; each tested material had a dose-dependent genotoxic effect, but graphene caused the most serious DNA damage (1 μg mL -1 ). By contrast, other nanoparticles, even CNTs, only induced DNA damage at a higher concentration of 100 μg mL -1 . Thus, research on the genotoxicity of GFNs is urgently needed. 5.3. In vivo Studies\nEvaluating the in vivo toxicity of graphene-based nanomaterials is essential prior to their use in\nbiomedical applications. However, studies have shown that GO accumulates in certain organs, such as the lungs and liver, which can lead to potential toxicity [107]. Table 2 depicted the in vivo study results of different model animals.\nTable 2. In vivo study results of different model animals\nStudy level\nModel animal\nDrug administration Detected site Test period Result Ref.\nIn vivo study\nMice Direct injection Lungs Short-term Serious and persistent lung\ninjury [83]\nMice Intravenous\ninjection\nLivers and spleens Long-term nontoxicity [111]\nMice Intravenous injection\nLungs, livers, and spleens Long-term acute injury and chronic inflammation\n[112]\nZebrafish embryos Direct injection embryos Short-term\nWide distribution without toxicity [114]\nRabbit and rat Dripping Eyes Short-term Limited toxicity [115]\nVarious studies utilized mice as model animals to evaluate the in vivo toxicity of GFNs.\nAccording to the literature, the lungs are the most likely organ for GFN accumulation. Pulmonary edema, pulmonary thromboembolism, and granuloma formation [108-110] were observed in lungs in several in vivo studies. Duch et al. [83] administered graphene-based nanomaterials directly into the lungs of mice, where GO induced serious and persistent lung injury. Yang et al. [111] explored the long-term in vivo biodistribution of PEGylated 125 I-labeled nanographene sheets; after\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nintravenous injection, the nanographene sheets mainly accumulated in the reticuloendothelial system (RES), including the liver and spleen, but toxicity was not induced at a dose of 20 mg kg -1 . Furthermore, Wen et al. [112] studied the long-term in vivo biodistribution of intravenously injected PSS-modified nano GO; the potential toxicity of the nanoparticles was systematically investigated for over six months. Examination of the blood biochemistry and histology revealed that the nanoparticles could induce acute liver injury and chronic inflammation of the lung, liver, and spleen.\nOther model animals can also be used to assess the in vivo toxicity of GFNs. The zebrafish,\nwhose genome has close homology to the human genome, is one of crucial preclinical models for in vivo toxicity studies [113]. This species has been utilized to test the in vivo toxicity of graphene-based nanomaterials. Gollavelli et al. [114] microinjected multi-functional graphene into zebrafish embryos; after a series of detections, significant abnormalities were not observed, and the zebrafish embryos’ survival rate was not affected, even though graphene was widely distributed in the zebrafish from head to tail. Wu et al. [115] exposed GO to rabbits’ and rats’ eyes occasionally and repeatedly in the short term. One hundred microliters of GO (100 μg/mL) was dripped into the conjunctival sac, and no pathological changes in the cornea, iris, conjunctiva, or chemosis were observed after the instillation of GO; using the same method, the short-term toxicity in rats was determined, and a high concentration (100 μg/mL) caused necrosis and shedding of the corneal epithelium, which could be alleviated by glutathione.\nAccording to the abovementioned studies, the main toxicity mechanisms of GFNs are oxidative\nstress and cell membrane damage. The generation of ROS induces the oxidative stress, which damages cellular macromolecules, such as proteins, DNA, and lipids [116]; the physical interaction between cells and graphene, which possesses sharp edges, causes cell membrane damage [117]. Given its hydrophobic surface, graphene can greatly affect cell membrane lipids and cause toxicity [116]. In addition, its antibacterial activity may be attributed to the loss of membrane integrity [85]. 5.4. Toxicity Reduction\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nGFNs are toxic to some cancer cells, as well as to bacteria and fungi, but several side effects in\nnormal cells limit their application. Thus, biocompatible and non-toxic materials are required for the modification GFNs to reduce their toxicity. PEG, a non-toxic and non-immunogenic material approved by the United States Food and Drug Administration (FDA) for internal use in humans, has been widely used to modify GFNs [118]. Yang et al. [111] coated ultra-small RGO with PEG through non-covalent modification before the nanoparticles were intravenously injected into mice at a dose of 20 mg kg -1 . The treated animals could gradually clear the RGO after intravenous injection, and sufficient evidence was not obtained to prove the existence of organ damage or inflammation in the mice. In another study by this group, the toxicity of GO and PEGylated GO was compared after oral and intraperitoneal administration to mice at high doses [119]. The PEGylated GO had limited intestinal adsorption via oral administration based on the tissue uptake. By contrast, high accumulation of PEGylated GO in the RES organs (liver and spleen) was observed after intraperitoneal administration. Further studies indicated that some GO and PEGylated GO was retained in the mouse body over a long period of time after intraperitoneal administration based on histological examination of organ slices and hematological analysis, but the toxicity of these materials towards the treated animals was not significant. Other biocompatible materials, such as CS [66], PVA [68], PEI [69, 81], sodium alginate [70], β-cyclodextrin [77], and dextran [109] can also be used to modify GFNs using covalent and non-covalent approaches, as mentioned in “4. Modification of Graphene”."
    }, {
      "heading" : "6. Drug Delivery Applications of Graphene",
      "text" : "Since Dai and colleagues utilized PEGylated GO to deliver SN38, a camptothecin (CPT)\nanalogue [38], graphene and GO have been extensively explored as novel drug carriers for drug delivery, including anti-cancer drugs, poorly soluble drugs, antibiotics, antibodies, peptides, and genes. In this section, we discuss the applications of graphene and GO in targeting, controlled, and multifunctional drug delivery. Table 3 depicted the characteristics of different graphene-based DDS.\nAC CE\nPT ED\nM AN\nUS CR\nIPT\nMethylene blue GO Non-covalent Hydrogen bonding LSD, ZPD Hela cells male HeLa tumor-bearing\nathymic nude mice [148]\nDOX GO Covalent Carboxyl TEM, AFM, FTIR, SQID,\nAASA, TGA - - [149]\nDOX GO Covalent Oxygen-containing groups TEM, SEM, XRD, FTIR, XPS, Raman spectra, TGA,\nSQID, ZPD\n- - [150]\nMultifunctional\nDOX RGO Covalent Oxygen-containing groups TEM, XRD U251 glioma\ncells - [151]\nDOX GO Covalent Carboxyl TEM, SQID, FTIR, UV Hela cells - [152] DOX GQD Covalent Oxygen-containing groups UV, DLS, ZPD, XPS, Raman spectra, TEM Hela cells - [153]\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T"
    }, {
      "heading" : "6.1. Internal-Stimulation Targeting DDSs",
      "text" : "A limited loading capacity and low degree of functionalization are the main causes of failure of\nsome existing drug carriers. Insufficient cellular uptake and non-specific accumulation in normal tissues limit their clinical application. Thus, efficient DDSs must be designed to enhance specific cellular uptake and reduce non-specific accumulation in normal tissues. The combination of carriers with specific ligands that can recognize corresponding receptors on the cancer cell surface or respond to the specific stimulations in microenvironment, such as pH or temperature changes, has been widely used as an efficient approach to developing DDSs; this DDS strategy is called internal-stimulation targeting DDS [120-124]. Stimulations that can respond to specific ligands are called internal stimulations. To date, specific ligands, including FA, polymers, polysaccharides, peptides, proteins and antibodies, have been applied to recognize internal stimulations to improve the delivery efficiency.\nGraphene/FA conjugates have shown high specificity and affinity for overexpressed FA receptors,\nwhich exist on the surface of cancer cells [125]. Park et al. [126] synthesized a novel anticancer drug carrier by conjugating RGO with FA via a completely non-covalent functionalization method. Hydrazine monohydrate was utilized to reduce GO at 80 °C and simultaneously conjugate RGO with FA (Fig. 6). This targeting drug-carrier had good dispersion stability and specifically targeted MDA-MB-231 cells over noncancerous MDCK cells; after doxorubicin (DOX) loading, the formulation significantly reduced the cell viability by 28.8% at 10 mg mL -1 in vitro. Zhang et al. [96] utilized the covalent approach to bind FA to NGO; sulfonic acid groups were used to maintain carrier stability in physiological solutions (Fig. 7). This DDS consisting of two anticancer drugs demonstrated a more efficient targeting delivery of anticancer drugs into MCF-7 cells than into A549 cells, which are FA receptor-negative cells. The cytotoxicity of this dual-drug anticancer DDS to MCF-7 cells was much higher than that of the DDS containing only one drug; thus, this development provides a promising approach to overcome the drug resistance of cancer cells.\nAC C\nEP TE\nD M\nAN U\nSC R\nIP\nT\nFig. 6. Synthesis and targeted uptake of DOX-loaded rGO/FA conjugates into MDA-MB-231 cancer cells. (Ref. 126)\nFig. 7. Preparation of FA–NGO conjugates. EDC = 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide; NHS = N-hydroxysuccinimide. (Ref. 96)\nYang et al. [127] utilized carboxymethyl CS and hyaluronic acid (HA) to modify GO via a\ncovalent approach; the modified GO was used as a carrier to encapsulate the anticancer drug DOX. The carrier achieved the targeting delivery of DOX to cancer cells that were over-expressing CD44 receptors, reducing their cell viability, but had little influence on L929 cells, which are CD44 receptor-negative cells. Similarly, Song et al. [128] fabricated a novel HA−GO−DOX nanohybrid using a simple and effective method; this nanohybrid had great physiological stability and a high drug loading capacity (42.9%) and entrapment efficiency (69.5%). The HA−GO−DOX nanohybrid also had the highest cytotoxicity compared with free DOX and GO−DOX, and the amount of DOX released from the HA−GO−DOX nanohybrid (39.9%) was much lower than the amounts of free DOX (87.7%) and GO−DOX (48.2%) detected at 24 h.\nAC C\nEP TE\nD\nM\nAN U\nSC R\nIP T\nPeptides and proteins can also be targeting ligands according to recent studies. Qiu et al. [129]\ndesigned a novel targeting carrier with arginine-glycine-aspartic acid (RGD) as the targeting ligand. The peptides specifically bound to “αvβ3” integrins that were overexpressed on the surface of cancer cells [130]. The synthesis is shown in Fig. 8. Transferrin (Tf) is an iron-transporting serum glycoprotein that binds to receptors that are overexpressed on the surface of glioma cells; Tf was used as a targeting ligand by Liu et al. [131] to develop a glioma-targeting DDS; the Tf−PEG−GO−DOX DDS exhibited a 115.4% drug loading capacity, with a lateral dimension of 100−400 nm. In vitro cytotoxicity tests revealed that Tf−PEG−GO−DOX intensified the cytotoxicity by 4.63 compared with PEG−GO−DOX. The in vivo results demonstrated that Tf increased the transport of DOX across the blood-brain barrier to reach the gliomas. Thus, this DDS significantly prolonged the lifespan of glioma-bearing rats.\nFig. 8. The synthesis, drug release, and interactions with cancer cells of the multifunctional GQDs. (Ref. 129)\nMoreover, antibodies can be used as targeting ligands. For example, Yang et al. [132] conjugated\na monoclonal antibody, that acts against the follicle-stimulating hormone receptor (FSHR), with GO to fabricate an efficient cancer-targeting DDS. This novel DDS exhibited excellent stability, high specificity for FSHR, and rapid tumor uptake and remained stable over time both in vitro and in vivo, which correspond to highly efficient anti-cancer drug delivery to tumors.\nFurthermore, many drugs and polymers can respond to specific pH values in the tumor\nmicroenvironment, and combining GFNs with these drugs or polymers can result in pH targeting. An et al. [133] prepared gelatin-functionalized graphene nanosheets attached to methotrexate (MTX) to obtain pH-dependent release behavior; the release profile showed that the amount of drug released under acidic conditions was much higher than that under neutral conditions. Regarding\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\npH-sensitive polymers, Liu et al. [134] designed a graphene/poly(acrylic acid) (PAA) hydrogel that was pH sensitive, mechanically strong, and thermally stable via reversible addition-fragmentation transfer (RAFT) polymerization; the controlled release profiles indicated that DOX was released more quickly at pH 7.4 than at 2.0, which is opposite the behavior expected based on the properties of DOX. Therefore, pH-sensitive release under neutral conditions, rather than under the acidic conditions of gastric acid, can protect the stomach from undesired drug release. Moreover, Bai et al. [135] utilized PVA to prepare a pH-sensitive GO composite hydrogel. The released amount of vitamin B12 (VB12) was approximately 51% at pH 1.7 and 84% at pH 7.4, respectively. The GO/PVA hydrogel exhibited a pH-sensitive gel–sol transition, which could protect acid-labile drugs from decomposing or causing stomach discomfort. Chen et al. [136] reported a CS derivatives/RGO/ alginate hydrogel beads for small-molecule drug delivery. The hydrogel beads possessed a slow release of 71.6% at 150 h in physiological medium, and a quick release of 82.8% at 20 h in acidic medium."
    }, {
      "heading" : "6.2. External-Field-Controlled DDSs",
      "text" : "Through external fields, such as electrical, thermal, light, and magnetic fields, the drug delivery\nand drug release of functional DDSs can be efficiently controlled; thus, DDSs could effectively act at the nidus, rather than releasing during drug transportation in blood circulation and leading to side effects. This DDS strategy is called external-field-controlled DDS [137-143].\nAn applied stimulus of an electric field has several advantages, including reliability and precise\ncontrol over the magnitude, duration and intervals of pulses. This application is limited by the instability of structures such as hydrogels after electric stimulation. To overcome this limitation in clinical applications, GFNs were introduced into hydrogel-based DDSs. Kenna et al. [144] established a novel electroconductive hydrogel-based electrostimulated drug carrier. This group utilized HA as the dispersing agent and then mixed RGO and polymers by vortexing; the mixture polymerized as a hydrogel at 4 °C. Their research showed an increasing electrostatic repulsion\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nbetween methyl orange (the model drug) and RGO; thus, the generation of a higher charge density at more negative voltages accelerated the release. Weaver et al. [145] designed an electrically controlled drug delivery nanocomposite composed of GO deposited in a conducting polymer scaffold. The nanocomposite released the drug after voltage stimulation with a linear release profile; the dosage could be controlled by changing the stimulation, such that no drug passively diffused from the nanocomposite without stimulation.\nLight is an extremely important controlling stimulus because its intensity and wavelength can be\neasily manipulated; in particular, light from an NIR laser penetrates human tissues well without causing harm [146]. Given the high optical absorbance in the NIR region, GO could be an effective photothermal material. Chen et al. [147] designed an RGO/PEG composite as a photothermally controllable DDS. RGO/PEG converted the absorbed light into local heat, which dissociated the strong interactions between resveratrol (RV) and its carrier, thereby releasing more RV molecules. The photothermally controlled mechanism of action of RGO/PEG–RV in inducing cell death is shown in Fig. 9. The in vitro results of the carriers showed no significant cytotoxicity without NIR irradiation at a high concentration of 100 μg mL -1 in 24 h, but significant cytotoxicity was observed within 30 min with NIR irradiation at 50 and 30 μg mL -1 GO/PEG and RGO/PEG, respectively. Notably, when cells were treated with RGO/PEG–RV and NIR irradiation for 3 min, the cytotoxicity was significantly enhanced. Furthermore, in vivo results demonstrated that RGO/PEG can deliver drug molecules in a remote and photothermally controllable way. In addition, Sahu et al. [148] fabricated a GO-mediated delivery system through a non-covalent approach with a Pluronic block copolymer and methylene blue for combined photodynamic therapy and photothermal therapy (PDT–PTT). Utilizing PDT–PTT, Pluronic-coated nano GO efficiently transported the photosensitizer into cancer cells to enhance the anticancer effect. Moreover, these nanoparticles effectively accumulated in tumor tissues. This combination of NIR light induced PDT via methylene blue and subsequent PTT via nano GO to completely destroy the tumor, thereby achieving the synergistic effect of these two phototherapies.\nAC C\nEP TE\nD M\nAN\nU\nSC R\nIP T\nFig. 9. Photothermally controlled action of NrGO/PEG-RV in inducing cell death (Ref. 147) .\nAs the most commonly used magnetic material for magnetic field-controlled drug-carrier systems,\nFe3O4 is well known for its superparamagnetism, low toxicity, and favorable biocompatibility in physiological environments. For example, Yang et al. [149] first prepared a superparamagnetic GO-Fe3O4 hybrid through chemical precipitation. This nanohybrid had a high drug loading capacity (1.08 mg mg -1 ) and high dispersion, and through the external magnetic field, the hybrid could move regularly to the action site. Similarly, Wang et al. [150] designed a cobalt ferrite/GO (CoFe2O4/GO) nanocomposite for magnetic resonance imaging (MRI) and controlled drug delivery. In combining CoFe2O4 with GO, the saturation magnetization was reduced from 94 emu/g to 38.7 emu/g, which means that the CoFe2O4/GO nanocomposite could more easily induce superparamagnetism. The superparamagnetic property allowed the nanocomposite to easily disperse in solution with negligible magnetic interactions between each composite, avoid magnetic clustering, and deliver drugs with high efficiency and accuracy with the assistance of an external magnetic field. 6.3. Multifunctional Carriers for Combined Therapy\nGiven the molecular complexity and defense mechanisms of a disease, conventional therapy with\nAC C\nEP TE\nD M\nU\nSC\nR\nIP T\nsingle treatments that can target only one object is inadequate [57]. Thus, combination therapy combines two or more therapeutic strategies on one drug delivery platform as an efficient solution in disease treatment (Fig. 10). In this approach, GFNs could be used as multifunctional drug delivery platforms because of their planar structures and high surface areas.\nin combination therapy. Wang et al. [151] prepared a novel multifunctional DDS for the chemo-photothermal targeted therapy of gliomas. The IL-13 peptide was used as the targeting ligand to recognize receptor chain 2 of interleukin 13, which is overexpressed in malignant tumors, and GO was used to absorb the NIR lasers due to its efficient heat transfer for photothermal therapy. In addition, the PEGylated mesoporous silica-coated GO could efficiently enhance the drug loading efficiency and reduce the toxicity in vivo. Cytotoxicity experiments revealed that the efficacy of the multifunctional DDS was superior to that of single chemotherapy or photothermal therapy. In addition, Yang et al. [152] established a dual-target drug delivery and pH-sensitive controlled DDS based on multifunctional GO. This system realized dual-target delivery via a magnetic field and the specific interaction between FA and the FA receptor overexpressed on the surface of some cancer cells. Moreover, certain fluorescent drugs, such as DOX, can be used to track and monitor drug delivery. Chen et al. [153] reported novel hybrid SiO2-coated quantum dot (QD)-conjugated graphene for targeting cancer fluorescent imaging, tracking and monitoring of drug delivery, and\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\ncancer therapy. By functionalizing this QD-conjugated graphene, the hybrid material realized the desired targeting behavior.\nCombination therapy is particularly important for improving efficacy and reducing dosage and\nside effects. In the future, multifunctional graphene derivatives as drug carriers will become the leading smart nanocarriers for cancer treatment."
    }, {
      "heading" : "7. Conclusion and Perspectives",
      "text" : "This review mentions a considerable number of publications on the characteristics, synthesis,\nmodification, drug delivery applications, and toxicity of GFNs. Its 2-D structure makes graphene a special nanocarrier with several unique advantages, such as a high surface area, high strength, easy modification, and good biocompatibility, compared with other spherical or tabulate nanomaterials. These advantages have led to the sharp increase in graphene applications for drug delivery. Modified graphene-based nanocarriers have potential in targeting, controlled, and multifunctional DDSs. However, the clinical application of these nanocarriers is limited by biosafety issues, including their cytotoxicity, in vivo toxicity, and even genotoxicity, which are influenced by the size, shape, charge, and modified groups. Furthermore, the bioaccumulation of graphene in certain organs, such as the lungs and liver, needs further investigation. Therefore, this review provides a guide for researchers in the selection of optimal approaches to fabricate the appropriate nanocarriers for medical treatment and to control the toxicity within therapeutic safety limits. Despite the numerous unresolved issues and challenges, the unique physicochemical properties of GFNs and the promising achievements mentioned above imply great theoretical and applied progress in biosafety and drug delivery. With the development of materialogy, the low toxicity and biocompatible materials would be utilized to modify GFNs to obtain a more biocompatible size, shape, or charge, and reduce the bioaccumulation impact. Under this condition, the GFNs with various of unique advantages will be extensively used in multifunctional DDSs, which a DDS will achieve drug delivery, drug tracking, health monitoring and adjuvant therapy synchronously.\nAC C\nEP TE\nD M\nAN U\nSC R\nIP T\nDeclaration of interest\nThe authors report no conflicts of interest in this work."
    }, {
      "heading" : "Acknowledgement",
      "text" : "This work was financially supported by National Natural Science Foundation of China (Project No. 81303233) and Shanghai Committee of Science and Technology (Project No. 13401900300 ). Author contributions\nB. Wang , T. Zhang and J.S. Tao contributed to the conception of the review; Q. Zhang and Z.N. Wu contributed significantly to complete manuscript preparation; N. Li and Y.Q. Pu contributed to the constructive discussions. All authors read and approved the review."
    } ],
    "references" : [ {
      "title" : "Mater",
      "author" : [ "M.I. Katsnelson" ],
      "venue" : "Today., 10 ",
      "citeRegEx" : "1",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "Graphene-new type of two-dimensional carbon nanomaterials",
      "author" : [ "Y. Chen", "Y. Huang", "Y. Ma", "Z. Liu", "X. Wan", "J. Liang", "X. Yang" ],
      "venue" : "Science Press, Beijing",
      "citeRegEx" : "2",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Nature",
      "author" : [ "Q. Huang", "D. Yu", "B. Xu", "W. Hu", "Y. Ma", "Y. Wang", "Z. Zhao", "B. Wen", "J. He", "Z. Liu", "Y. Tian" ],
      "venue" : "510 ",
      "citeRegEx" : "3",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Nature",
      "author" : [ "K.S. Kim", "Y. Zhao", "H. Jang", "S.Y. Lee", "J.M. Kim", "K.S. Kim", "J.H. Ahn", "P. Kim", "J.Y. Choi", "B.H. Hong" ],
      "venue" : "457 ",
      "citeRegEx" : "4",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Prog",
      "author" : [ "R. Sengupta", "M. Bhattacharya", "S. Bandyopadhyay", "A.K. Bhowmick" ],
      "venue" : "Polym. Sci., 36 ",
      "citeRegEx" : "5",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Nano",
      "author" : [ "A.S. Mayorov", "D.C. Elias", "I.S. Mukhin", "S.V. Morozov", "L.A. Ponomarenko", "K.S. Novoselov", "A.K. Geim", "R.V. Gorbachev" ],
      "venue" : "Lett., 12 ",
      "citeRegEx" : "6",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Nanoscale",
      "author" : [ "C. Li", "G. Shi" ],
      "venue" : "4 ",
      "citeRegEx" : "7",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "ACS Nano",
      "author" : [ "L. Qu", "Y. Liu", "J. Baek", "L. Dai" ],
      "venue" : "4 ",
      "citeRegEx" : "8",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Carbon",
      "author" : [ "S. Stankovich", "D.A. Dikin", "R.D. Piner", "K.A. Kohlhaas", "A. Kleinhammes", "Y. Jia", "Y. Wu", "S.T. Nguyen", "R.S. Ruoff" ],
      "venue" : "45 ",
      "citeRegEx" : "9",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "Biosens Bioelectron",
      "author" : [ "S. Ge", "M. Yan", "J. Lu", "M. Zhang", "F. Yu", "J. Yu", "X. Song", "S. Yu" ],
      "venue" : "31 ",
      "citeRegEx" : "10",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Chem",
      "author" : [ "X. Wang", "G. Sun", "P. Routh", "D.-H. Kim", "W. Huang", "P. Chen" ],
      "venue" : "Soc. Rev., 43 ",
      "citeRegEx" : "11",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Energ",
      "author" : [ "D. Chen", "H. Zhang", "Y. Liu", "J. Li" ],
      "venue" : "Environ. Sci., 6 ",
      "citeRegEx" : "12",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Materials Today",
      "author" : [ "Y. Yang", "A.M. Asiri", "Z. Tang", "D. Du", "Y. Lin" ],
      "venue" : "16 ",
      "citeRegEx" : "13",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Science",
      "author" : [ "A.K. Geim" ],
      "venue" : "324 ",
      "citeRegEx" : "14",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Organomet",
      "author" : [ "S. De", "S. Mohanty", "S.K. Nayak", "J. Inorg" ],
      "venue" : "P., 25 ",
      "citeRegEx" : "15",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Langmuir : the ACS journal of surfaces and colloids",
      "author" : [ "X. Zhao", "L. Liu", "X. Li", "J. Zeng", "X. Jia", "P. Liu" ],
      "venue" : "30 ",
      "citeRegEx" : "16",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Adv",
      "author" : [ "K. Yang", "L. Hu", "X. Ma", "S. Ye", "L. Cheng", "X. Shi", "C. Li", "Y. Li", "Z. Liu" ],
      "venue" : "Mater., 24 ",
      "citeRegEx" : "17",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "Y. Sheng", "L.D. Liao", "A. Bandla", "Y.H. Liu", "J. Yuan", "N. Thakor", "M.C. Tan" ],
      "venue" : "70 ",
      "citeRegEx" : "18",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Science",
      "author" : [ "K. Novoselov", "A. Geim", "S. Morozov", "D. Jiang", "Y. Zhang", "S. Dubonos", "I. Grigorieva", "A. Firsov" ],
      "venue" : "306 ",
      "citeRegEx" : "20",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "Nature Materials",
      "author" : [ "A. Geim", "K. Novoselov" ],
      "venue" : "6 ",
      "citeRegEx" : "21",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "Adv",
      "author" : [ "L. Feng", "L. Wu", "X. Qu" ],
      "venue" : "Mater., 25 ",
      "citeRegEx" : "22",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Trends in Biotechnology",
      "author" : [ "Y. Wang", "Z. Li", "J. Wang", "J. Li", "Y. Lin" ],
      "venue" : "29 ",
      "citeRegEx" : "23",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Mater",
      "author" : [ "X. Zhang", "C. Yu", "C. Wang", "Z. Wang", "J. Qiu" ],
      "venue" : "Res. Bull., 67 ",
      "citeRegEx" : "24",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "S. Jahanbani", "A. Benvidi" ],
      "venue" : "68 ",
      "citeRegEx" : "25",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "M. Hasanzadeh", "N. Shadjou", "A. Mokhtarzadeh", "M. Ramezani" ],
      "venue" : "68 ",
      "citeRegEx" : "26",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "W. Wu", "B. Yu", "H. Wu", "S. Wang", "Q. Xia", "Y. Ding" ],
      "venue" : "70 ",
      "citeRegEx" : "27",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "S. Mutyala", "J. Mathiyarasu" ],
      "venue" : "69 ",
      "citeRegEx" : "28",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "D. Wang", "F. Xu", "J. Hu", "M. Lin" ],
      "venue" : "71 ",
      "citeRegEx" : "29",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "L. Daneshvar", "G.H. Rounaghi", "Z. Es'haghi", "M. Chamsaz", "S. Tarahomi" ],
      "venue" : "69 ",
      "citeRegEx" : "30",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "D. Zhang", "L. Li", "W. Ma", "X. Chen", "Y. Zhang" ],
      "venue" : "70 ",
      "citeRegEx" : "31",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Chem",
      "author" : [ "R.G. Mendes", "A. Bachmatiuk", "B. Büchner", "G. Cuniberti", "M.H. Rümmeli", "J. Mater" ],
      "venue" : "B, 1 ",
      "citeRegEx" : "32",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Adv",
      "author" : [ "Y. Zhu", "S. Murali", "W. Cai", "X. Li", "J.W. Suk", "J.R. Potts", "R.S. Ruoff" ],
      "venue" : "Mater., 22 ",
      "citeRegEx" : "33",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "E",
      "author" : [ "Y. Zhang", "S.F. Ali" ],
      "venue" : "Dervishi, Y.X. Xu, Yang., Z. Li, D. Casciano, A.S. Biris, ACS Nano, 4 ",
      "citeRegEx" : "34",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Nat",
      "author" : [ "M.E. Davis", "Z.G. Chen", "D.M. Shin" ],
      "venue" : "Rev. Drug. Discov., 7 ",
      "citeRegEx" : "35",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "N. Mahmoudi", "A. Simchi" ],
      "venue" : "70 ",
      "citeRegEx" : "36",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Nano Research",
      "author" : [ "X. Sun", "Z. Liu", "K. Welsher", "J.T. Robinson", "A. Goodwin", "S. Zaric", "H. Dai" ],
      "venue" : "1 ",
      "citeRegEx" : "37",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "Chem",
      "author" : [ "Z. Liu", "J.T. Robinson", "X. Sun", "H. Dai", "J. Am" ],
      "venue" : "Soc., 130 ",
      "citeRegEx" : "38",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "ChemSusChem",
      "author" : [ "Y.H. Hu", "H. Wang", "B. Hu" ],
      "venue" : "3 ",
      "citeRegEx" : "39",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "G. Sharma", "D. Kumar", "A. Kumar", "A.H. Al-Muhtaseb", "D. Pathania", "M. Naushad", "G.T. Mola" ],
      "venue" : "71 ",
      "citeRegEx" : "40",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "M. Hasanzadeh", "N. Shadjou" ],
      "venue" : "71 ",
      "citeRegEx" : "41",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "Z. Li", "S.L. Wong" ],
      "venue" : "70 ",
      "citeRegEx" : "42",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Journal of Physical Chemistry",
      "author" : [ "H. Schniepp", "J. Li", "M. McAllister", "H. Sai", "M. Herrera-Alonso", "D. Adamson", "R. Prud'homme", "R. Car", "D. Saville", "I. Aksay" ],
      "venue" : "B, 110 ",
      "citeRegEx" : "45",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "The Journal of Physical Chemistry",
      "author" : [ "K.S. Subrahmanyam", "L.S. Panchakarla", "A. Govindaraj", "C.N.R. Rao" ],
      "venue" : "C, 113 ",
      "citeRegEx" : "47",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Chem",
      "author" : [ "C. Simpson", "G. Mattersteig", "K. Martin", "L. Gherghel", "R. Bauer", "H. Rader", "K. Mullen", "J. Am" ],
      "venue" : "Soc., 126 ",
      "citeRegEx" : "48",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "Nat",
      "author" : [ "M. Treier", "C.A. Pignedoli", "T. Laino", "R. Rieger", "K. Muellen", "D. Passerone", "R. Fasel" ],
      "venue" : "Chem., 3 ",
      "citeRegEx" : "49",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Angewandte Chemie(International Edition)",
      "author" : [ "P. Siemsen", "R. Livingston", "F. Diederich" ],
      "venue" : "39 ",
      "citeRegEx" : "50",
      "shortCiteRegEx" : null,
      "year" : 2000
    }, {
      "title" : "Acad",
      "author" : [ "M.J. Schultz", "X. Zhang", "S. Unarunotai", "D.Y. Khang", "Q. Cao", "C. Wang", "C. Lei", "S. MacLaren", "J.A. Soares", "I. Petrov", "J.S. Moore", "J.A. Rogers", "P. Natl" ],
      "venue" : "Sci. USA., 105 ",
      "citeRegEx" : "51",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "Adv",
      "author" : [ "W. Zhang", "J.S. Moore" ],
      "venue" : "Synth. Catal., 349 ",
      "citeRegEx" : "52",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "Chem",
      "author" : [ "P.R. Somani", "S.P. Somani", "M. Umeno" ],
      "venue" : "Phys. Lett., 430 ",
      "citeRegEx" : "53",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Carbon",
      "author" : [ "J. Wang", "M. Zhu", "R.A. Outlaw", "X. Zhao", "D.M. Manos", "B.C. Holloway" ],
      "venue" : "42 ",
      "citeRegEx" : "54",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "Carbon",
      "author" : [ "C.-D. Kim", "B.-K. Min", "W.-S. Jung" ],
      "venue" : "47 ",
      "citeRegEx" : "56",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Acta Biomater",
      "author" : [ "J. Liu", "L. Cui", "D. Losic" ],
      "venue" : "9 ",
      "citeRegEx" : "57",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Chemical Society reviews",
      "author" : [ "D.R. Dreyer", "S. Park", "C.W. Bielawski", "R.S. Ruoff" ],
      "venue" : "39 ",
      "citeRegEx" : "58",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "The Journal of Physical Chemistry B",
      "author" : [ "A. Lerf", "H. He", "M. Forster", "J. Klinowski" ],
      "venue" : "102 ",
      "citeRegEx" : "59",
      "shortCiteRegEx" : null,
      "year" : 1998
    }, {
      "title" : "Nankai University",
      "author" : [ "W. Yan" ],
      "venue" : "Tianjin",
      "citeRegEx" : "60",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Carbon",
      "author" : [ "S. Stankovich", "R.D. Piner", "S.T. Nguyen", "R.S. Ruoff" ],
      "venue" : "44 ",
      "citeRegEx" : "61",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "M. Golestanzadeh", "H. Naeimi", "Z. Zahraie" ],
      "venue" : "71 ",
      "citeRegEx" : "62",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "S.N. Yazid", "I.M. Isa", "N. Hashim" ],
      "venue" : "68 ",
      "citeRegEx" : "63",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "S.H. Kazemi", "E. Ghodsi", "S. Abdollahi", "S. Nadri" ],
      "venue" : "69 ",
      "citeRegEx" : "64",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "Q. Ren", "L. Feng", "R. Fan", "X. Ge", "Y. Sun" ],
      "venue" : "68 ",
      "citeRegEx" : "65",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Biomaterials",
      "author" : [ "L. Chen", "X. Zhong", "X. Yi", "M. Huang", "P. Ning", "T. Liu", "C. Ge", "Z. Chai", "Z. Liu", "K. Yang" ],
      "venue" : "66 ",
      "citeRegEx" : "67",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "J",
      "author" : [ "X. Peng", "C. He", "J. Liu", "H. Wang" ],
      "venue" : "Mater. Sci., 51 ",
      "citeRegEx" : "68",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Analytica Chimica Acta",
      "author" : [ "B. Jiang", "Y. Qu", "L. Zhang", "Z. Liang", "Y. Zhang" ],
      "venue" : "912 ",
      "citeRegEx" : "69",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Journal of Applied Polymer Science",
      "author" : [ "H. Hu", "J. Yu", "Y. Li", "J. Zhao", "H. Dong" ],
      "venue" : "100 ",
      "citeRegEx" : "71",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Compos",
      "author" : [ "J. Ma", "Q. Meng", "I. Zaman", "S. Zhu", "A. Michelmore", "N. Kawashima", "C.H. Wang", "H.-C. Kuan" ],
      "venue" : "Sci. Technol., 91 ",
      "citeRegEx" : "72",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Macromolecules",
      "author" : [ "F. Beckert", "A.M. Rostas", "R. Thomann", "S. Weber", "E. Schleicher", "C. Friedrich", "R. Mülhaupt" ],
      "venue" : "46 ",
      "citeRegEx" : "73",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Anal",
      "author" : [ "S. Chaiyo", "E. Mehmeti", "K. Zagar", "W. Siangproh", "O. Chailapakul", "K. Kalcher" ],
      "venue" : "Chim. Acta, 918 ",
      "citeRegEx" : "74",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Chem",
      "author" : [ "J. Che", "L. Shen", "Y. Xiao", "J. Mater" ],
      "venue" : "20 ",
      "citeRegEx" : "75",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "J",
      "author" : [ "S. Stankovich", "R.D. Piner", "X. Chen", "N. Wu", "S.T. Nguyen", "R.S. Ruoff" ],
      "venue" : "Mater. Chem., 16 ",
      "citeRegEx" : "76",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Chem-Eur",
      "author" : [ "Y. Yang", "Y.M. Zhang", "Y. Chen", "D. Zhao", "J.T. Chen", "Y. Liu" ],
      "venue" : "J., 18 ",
      "citeRegEx" : "77",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Environ",
      "author" : [ "J. Wang", "Z. Chen", "B. Chen" ],
      "venue" : "Sci. Technol., 48 ",
      "citeRegEx" : "78",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "A. Azadbakht", "M. Roushani", "A.R. Abbasi", "Z. Derikvand", "S. Menati" ],
      "venue" : "69 ",
      "citeRegEx" : "79",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Nano",
      "author" : [ "H. Wang", "X. Wang", "X. Li", "H. Dai" ],
      "venue" : "Res., 2 ",
      "citeRegEx" : "80",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "ACS Nano",
      "author" : [ "O.C. Compton", "S.W. Cranford", "K.W. Putz", "Z. An", "L.C. Brinson", "M.J. Buehler", "S.T. Nguyen" ],
      "venue" : "6 ",
      "citeRegEx" : "81",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "B. Wang", "Y.S. Jeon", "H.S. Park", "J.H. Kim" ],
      "venue" : "69 ",
      "citeRegEx" : "82",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Nano",
      "author" : [ "M.C. Duch", "G.R. Budinger", "Y.T. Liang", "S. Soberanes", "D. Urich", "S.E. Chiarella", "L.A. Campochiaro", "A. Gonzalez", "N.S. Chandel", "M.C. Hersam", "G.M. Mutlu" ],
      "venue" : "Lett., 11 ",
      "citeRegEx" : "83",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Small",
      "author" : [ "L. Zhang", "Z. Lu", "Q. Zhao", "J. Huang", "H. Shen", "Z. Zhang" ],
      "venue" : "7 ",
      "citeRegEx" : "84",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "ACS Nano",
      "author" : [ "S. Liu", "T.H. Zeng", "M. Hofmann", "E. Burcombe", "J. Wei", "R. Jiang", "J. Kong", "Y. Chen" ],
      "venue" : "5 ",
      "citeRegEx" : "85",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Mater",
      "author" : [ "A.M. Diez-Pascual", "A.L. Diez-Vicente", "ACS Appl" ],
      "venue" : "Interfaces., 8 ",
      "citeRegEx" : "86",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "ACS Nano",
      "author" : [ "O. Akhavan", "E. Ghaderi" ],
      "venue" : "4 ",
      "citeRegEx" : "87",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Nanotechnology",
      "author" : [ "C.M. Santos", "J. Mangadlao", "F. Ahmed", "A. Leon", "R.C. Advincula", "D.F. Rodrigues" ],
      "venue" : "23 ",
      "citeRegEx" : "88",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Int",
      "author" : [ "S. Gurunathan", "J.W. Han", "A.A. Dayem", "V. Eppakayala", "J.H. Kim" ],
      "venue" : "J. Nanomed., 7 ",
      "citeRegEx" : "89",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "J",
      "author" : [ "J. Chen", "X. Wang", "H. Han" ],
      "venue" : "Nanopart. Res., 15 ",
      "citeRegEx" : "90",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "J",
      "author" : [ "J. Ma", "J. Zhang", "Z. Xiong", "Y. Yong", "X.S. Zhao" ],
      "venue" : "Mater. Chem., 21 ",
      "citeRegEx" : "91",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "J",
      "author" : [ "W.-P. Xu", "L.-C. Zhang", "J.-P. Li", "Y. Lu", "H.-H. Li", "Y.-N. Ma", "W.-D. Wang", "S.-H. Yu" ],
      "venue" : "Mater. Chem., 21 ",
      "citeRegEx" : "92",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Nanoscale Research Letters",
      "author" : [ "S.W. Chook", "C.H. Chia", "S. Zakaria", "M.K. Ayob", "K.L. Chee", "N.M. Huang", "H.M. Neoh", "H.N. Lim", "R. Jamal", "R.M.F.R.A. Rahman" ],
      "venue" : "7 ",
      "citeRegEx" : "93",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Carbon",
      "author" : [ "M. Sawangphruk", "P. Srimuk", "P. Chiochan", "T. Sangsri", "P. Siwayaprahm" ],
      "venue" : "50 ",
      "citeRegEx" : "94",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "B.B. Shotorbani", "E. Alizadeh", "R. Salehi", "A. Barzegar" ],
      "venue" : "71 ",
      "citeRegEx" : "95",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Small",
      "author" : [ "L. Zhang", "J. Xia", "Q. Zhao", "L. Liu", "Z. Zhang" ],
      "venue" : "6 ",
      "citeRegEx" : "96",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Particle and Fibre Toxicology",
      "author" : [ "T. Lammel", "P. Boisseaux", "M.-L. Fernandez-Cruz", "J.M. Navas" ],
      "venue" : "10 ",
      "citeRegEx" : "97",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Biomaterials",
      "author" : [ "O. Akhavan", "E. Ghaderi", "A. Akhavan" ],
      "venue" : "33 ",
      "citeRegEx" : "98",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Biomaterials",
      "author" : [ "Y. Li", "Y. Liu", "Y. Fu", "T. Wei", "L. Le Guyader", "G. Gao", "R.S. Liu", "Y.Z. Chang", "C. Chen" ],
      "venue" : "33 ",
      "citeRegEx" : "99",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Mater",
      "author" : [ "K.H. Liao", "Y.S. Lin", "C.W. Macosko", "C.L. Haynes", "ACS Appl" ],
      "venue" : "Interfaces., 3 ",
      "citeRegEx" : "100",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Biomaterials",
      "author" : [ "S. Mullick Chowdhury", "G. Lalwani", "K. Zhang", "J.Y. Yang", "K. Neville", "B. Sitharaman" ],
      "venue" : "34 ",
      "citeRegEx" : "101",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Int",
      "author" : [ "S. Jaworski", "E. Sawosz", "M. Kutwin", "M. Wierzbicki", "M. Hinzmann", "M. Grodzik", "A. Winnicka", "L. Lipinska", "K. Wlodyga", "A. Chwalibog" ],
      "venue" : "J. Nanomed., 10 ",
      "citeRegEx" : "102",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Int",
      "author" : [ "S. Gurunathan", "J.W. Han", "E.S. Kim", "J.H. Park", "J.H. Kim" ],
      "venue" : "J. Nanomed., 10 ",
      "citeRegEx" : "103",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Int",
      "author" : [ "S. Gurunathan", "J.W. Han", "V. Eppakayala", "J.H. Kim" ],
      "venue" : "J. Nanomed., 8 ",
      "citeRegEx" : "104",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Blood",
      "author" : [ "L. Agemy", "K.N. Sugahara", "V.R. Kotamraju", "K. Gujraty", "O.M. Girard", "Y. Kono", "R.F. Mattrey", "J.H. Park", "M.J. Sailor", "A.I. Jimenez", "C. Cativiela", "D. Zanuy", "F.J. Sayago", "C. Aleman", "R. Nussinov", "E. Ruoslahti" ],
      "venue" : "116 ",
      "citeRegEx" : "105",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Anal",
      "author" : [ "Y. Qiao", "J. An", "L. Ma" ],
      "venue" : "Chem. , 85 ",
      "citeRegEx" : "106",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Angew",
      "author" : [ "A. Bianco" ],
      "venue" : "Chem. Int. Ed. Engl., 52 ",
      "citeRegEx" : "107",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "ACS Nano",
      "author" : [ "A. Schinwald", "F.A. Murphy", "A. Jones", "W. MacNee", "K. Donaldson" ],
      "venue" : "6 ",
      "citeRegEx" : "108",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Carbon",
      "author" : [ "S. Zhang", "K. Yang", "L. Feng", "Z. Liu" ],
      "venue" : "49 ",
      "citeRegEx" : "109",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Carbon",
      "author" : [ "X. Zhang", "J. Yin", "C. Peng", "W. Hu", "Z. Zhu", "W. Li", "C. Fan", "Q. Huang" ],
      "venue" : "49 ",
      "citeRegEx" : "110",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "ACS Nano",
      "author" : [ "K. Yang", "J. Wan", "S. Zhang", "Y. Zhang", "S.-T. Lee", "Z. Liu" ],
      "venue" : "5 ",
      "citeRegEx" : "111",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "J Appl Toxicol",
      "author" : [ "K.P. Wen", "Y.C. Chen", "C.H. Chuang", "H.Y. Chang", "C.Y. Lee", "N.H. Tai" ],
      "venue" : "35 ",
      "citeRegEx" : "112",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Adv",
      "author" : [ "V.E. Fako", "D.Y. Furgeson" ],
      "venue" : "Drug. Deliver. Rev., 61 ",
      "citeRegEx" : "113",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Biomaterials",
      "author" : [ "G. Gollavelli", "Y.C. Ling" ],
      "venue" : "33 ",
      "citeRegEx" : "114",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Nanotoxicology",
      "author" : [ "W. Wu", "L. Yan", "Q. Wu", "Y. Li", "Q. Li", "S. Chen", "Y. Yang", "Z. Gu", "H. Xu", "Z.Q. Yin" ],
      "venue" : "10 ",
      "citeRegEx" : "115",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Environ",
      "author" : [ "J. Zhao", "Z. Wang", "J.C. White", "B. Xing" ],
      "venue" : "Sci. Technol., 48 ",
      "citeRegEx" : "116",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "ACS Nano",
      "author" : [ "W. Hu", "C. Peng", "W. Luo", "M. Lv", "X. Li", "D. Li", "Q. Huang", "C. Fan" ],
      "venue" : "4 ",
      "citeRegEx" : "117",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Adv",
      "author" : [ "G. Goncalves", "M. Vila", "M.T. Portoles", "M. Vallet-Regi", "J. Gracio", "P.A. Marques" ],
      "venue" : "Healthc. Mater., 2 ",
      "citeRegEx" : "118",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Biomaterials",
      "author" : [ "K. Yang", "H. Gong", "X. Shi", "J. Wan", "Y. Zhang", "Z. Liu" ],
      "venue" : "34 ",
      "citeRegEx" : "119",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Chem",
      "author" : [ "Z. Wang", "D. Wu", "J. Zou", "Q. Zhou", "W. Liu", "W. Zhang", "G. Zhou", "X. Wang", "G. Pei", "Y. Cao", "Z.-Y. Zhang", "J. Mater" ],
      "venue" : "B, 5 ",
      "citeRegEx" : "120",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Prog",
      "author" : [ "Z. Li", "B.H. Tan", "T. Lin", "C. He" ],
      "venue" : "Polym. Sci., 62 ",
      "citeRegEx" : "121",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Chemistry",
      "author" : [ "A.A. Karim", "Q. Dou", "Z. Li", "X.J. Loh" ],
      "venue" : "an Asian journal, 11 ",
      "citeRegEx" : "122",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Polym",
      "author" : [ "X. Fan", "Z. Li", "X.J. Loh" ],
      "venue" : "Chem., 7 ",
      "citeRegEx" : "123",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "ACS applied materials & interfaces",
      "author" : [ "X. Fan", "J.Y. Chung", "Y.X. Lim", "Z. Li", "X.J. Loh" ],
      "venue" : "8 ",
      "citeRegEx" : "124",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Chem",
      "author" : [ "Y. Song", "Y. Chen", "L. Feng", "J. Ren", "X. Qu" ],
      "venue" : "Commun., 47 ",
      "citeRegEx" : "125",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Journal of Industrial and Engineering Chemistry",
      "author" : [ "Y.H. Park", "S.Y. Park", "I. In" ],
      "venue" : "30 ",
      "citeRegEx" : "126",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Carbohyd",
      "author" : [ "H. Yang", "D.H. Bremner", "L. Tao", "H. Li", "J. Hu", "L. Zhu" ],
      "venue" : "Polym., 135 ",
      "citeRegEx" : "127",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Mater",
      "author" : [ "E. Song", "W. Han", "C. Li", "D. Cheng", "L. Li", "L. Liu", "G. Zhu", "Y. Song", "W. Tan", "ACS Appl" ],
      "venue" : "Interfaces., 6 ",
      "citeRegEx" : "128",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Int",
      "author" : [ "J. Qiu", "R. Zhang", "J. Li", "Y. Sang", "W. Tang", "P. Rivera Gil", "H. Liu" ],
      "venue" : "J. Nanomed., 10 ",
      "citeRegEx" : "129",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Mol",
      "author" : [ "F. Danhier", "A. Le Breton", "V. Preat" ],
      "venue" : "Pharm., 9 ",
      "citeRegEx" : "130",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Mater",
      "author" : [ "G. Liu", "H. Shen", "J. Mao", "L. Zhang", "Z. Jiang", "T. Sun", "Q. Lan", "Z. Zhang", "ACS Appl" ],
      "venue" : "Interfaces., 5 ",
      "citeRegEx" : "131",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Biomaterials",
      "author" : [ "D. Yang", "L. Feng", "C.A. Dougherty", "K.E. Luker", "D. Chen", "M.A. Cauble", "M.M. Banaszak Holl", "G.D. Luker", "B.D. Ross", "Z. Liu", "H. Hong" ],
      "venue" : "104 ",
      "citeRegEx" : "132",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "J. An", "Y. Gou", "C. Yang", "F. Hu", "C. Wang" ],
      "venue" : "33 ",
      "citeRegEx" : "133",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Eur",
      "author" : [ "J. Liu", "L. Cui", "N. Kong", "C.J. Barrow", "W. Yang" ],
      "venue" : "Polym. J., 50 ",
      "citeRegEx" : "134",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Chem",
      "author" : [ "H. Bai", "C. Li", "X. Wang", "G. Shi" ],
      "venue" : "Commun., 46 ",
      "citeRegEx" : "135",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "K. Chen", "Y. Ling", "C. Cao", "X. Li", "X. Chen", "X. Wang" ],
      "venue" : "69 ",
      "citeRegEx" : "136",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "X. Fan", "S. Jiang", "Z. Li", "X.J. Loh" ],
      "venue" : "73 ",
      "citeRegEx" : "137",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "ACS applied materials & interfaces",
      "author" : [ "Z. Li", "D. Yuan", "G. Jin", "B.H. Tan", "C. He" ],
      "venue" : "8 ",
      "citeRegEx" : "138",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "David",
      "author" : [ "Z. Li", "E. Ye" ],
      "venue" : "R. Lakshminarayanan, X.J. Loh, Small, 12 ",
      "citeRegEx" : "139",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "R",
      "author" : [ "Z. Li", "P.L. Chee", "C. Owh" ],
      "venue" : "Lakshminarayanan, X.J. Loh, RSC Adv., 6 ",
      "citeRegEx" : "140",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Z",
      "author" : [ "J.Y. Hwang" ],
      "venue" : "Li, X.J. Loh, RSC Adv., 6 ",
      "citeRegEx" : "141",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Chemical Society reviews",
      "author" : [ "Z. Li", "X.J. Loh" ],
      "venue" : "44 ",
      "citeRegEx" : "142",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Mater Sci Eng C Mater Biol Appl",
      "author" : [ "Z. Li", "B.H. Tan" ],
      "venue" : "45 ",
      "citeRegEx" : "143",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Chem",
      "author" : [ "N. Mac Kenna", "P. Calvert", "A. Morrin", "G.G. Wallace", "S.E. Moulton", "J. Mater" ],
      "venue" : "B, 3 ",
      "citeRegEx" : "144",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "ACS Nano",
      "author" : [ "C.L. Weaver", "J.M. LaRosa", "X. Luo", "X.T. Cui" ],
      "venue" : "8 ",
      "citeRegEx" : "145",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Chem",
      "author" : [ "X. Huang", "I. El-Sayed", "W. Qian", "M. El-Sayed", "J. Am" ],
      "venue" : "Soc., 128 ",
      "citeRegEx" : "146",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Biomaterials",
      "author" : [ "J. Chen", "H. Liu", "C. Zhao", "G. Qin", "G. Xi", "T. Li", "X. Wang", "T. Chen" ],
      "venue" : "35 ",
      "citeRegEx" : "147",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Biomaterials",
      "author" : [ "A. Sahu", "W.I. Choi", "J.H. Lee", "G. Tae" ],
      "venue" : "34 ",
      "citeRegEx" : "148",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "J",
      "author" : [ "X. Yang", "X. Zhang", "Y. Ma", "Y. Huang", "Y. Wang", "Y. Chen" ],
      "venue" : "Mater. Chem., 19 ",
      "citeRegEx" : "149",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Chem",
      "author" : [ "G. Wang", "Y. Ma", "Z. Wei", "M. Qi" ],
      "venue" : "Eng. J., 289 ",
      "citeRegEx" : "150",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Chem",
      "author" : [ "Y. Wang", "K. Wang", "J. Zhao", "X. Liu", "J. Bu", "X. Yan", "R. Huang", "J. Am" ],
      "venue" : "Soc., 135 ",
      "citeRegEx" : "151",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "J",
      "author" : [ "X. Yang", "Y. Wang", "X. Huang", "Y. Ma", "Y. Huang", "R. Yang", "H. Duan", "Y. Chen" ],
      "venue" : "Mater. Chem., 21 ",
      "citeRegEx" : "152",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Bioconjugate",
      "author" : [ "M.L. Chen", "Y.J. He", "X.W. Chen", "J.H. Wang" ],
      "venue" : "Chem., 24 ",
      "citeRegEx" : "153",
      "shortCiteRegEx" : null,
      "year" : 2013
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "Carbon is one of the most abundant elements in nature; carbon atoms can form complicated networks that are fundamental to organic chemistry and the existence of life [1].",
      "startOffset" : 166,
      "endOffset" : 169
    }, {
      "referenceID" : 1,
      "context" : "material that can exist in forms that range from zero-dimensional (0-D) to three-dimensional (3-D) [2].",
      "startOffset" : 99,
      "endOffset" : 102
    }, {
      "referenceID" : 2,
      "context" : "In addition, allotropes of carbon have various properties, from hard (diamond) to soft (graphite), from insulative (diamond) to semi-conductive (graphite) and conductive (graphene), and from light absorbing (graphite) to diaphanous (diamond) [3-5].",
      "startOffset" : 242,
      "endOffset" : 247
    }, {
      "referenceID" : 3,
      "context" : "In addition, allotropes of carbon have various properties, from hard (diamond) to soft (graphite), from insulative (diamond) to semi-conductive (graphite) and conductive (graphene), and from light absorbing (graphite) to diaphanous (diamond) [3-5].",
      "startOffset" : 242,
      "endOffset" : 247
    }, {
      "referenceID" : 4,
      "context" : "In addition, allotropes of carbon have various properties, from hard (diamond) to soft (graphite), from insulative (diamond) to semi-conductive (graphite) and conductive (graphene), and from light absorbing (graphite) to diaphanous (diamond) [3-5].",
      "startOffset" : 242,
      "endOffset" : 247
    }, {
      "referenceID" : 5,
      "context" : "Graphite and its allotropes, such as graphene, graphene oxide (GO), carbon nanotubes (CNTs), and reduced graphene oxide (RGO), have attracted extensive interest for use in quantum physics [6],",
      "startOffset" : 188,
      "endOffset" : 191
    }, {
      "referenceID" : 3,
      "context" : "nanoelectronics [4, 7], catalysis [8], nanocomposites [9], and sensor technology [10] because of their unique structure and geometry.",
      "startOffset" : 16,
      "endOffset" : 22
    }, {
      "referenceID" : 6,
      "context" : "nanoelectronics [4, 7], catalysis [8], nanocomposites [9], and sensor technology [10] because of their unique structure and geometry.",
      "startOffset" : 16,
      "endOffset" : 22
    }, {
      "referenceID" : 7,
      "context" : "nanoelectronics [4, 7], catalysis [8], nanocomposites [9], and sensor technology [10] because of their unique structure and geometry.",
      "startOffset" : 34,
      "endOffset" : 37
    }, {
      "referenceID" : 8,
      "context" : "nanoelectronics [4, 7], catalysis [8], nanocomposites [9], and sensor technology [10] because of their unique structure and geometry.",
      "startOffset" : 54,
      "endOffset" : 57
    }, {
      "referenceID" : 9,
      "context" : "nanoelectronics [4, 7], catalysis [8], nanocomposites [9], and sensor technology [10] because of their unique structure and geometry.",
      "startOffset" : 81,
      "endOffset" : 85
    }, {
      "referenceID" : 10,
      "context" : "Graphite and its allotropes possess outstanding physicochemical properties, including high fracture strength and Young’s modulus, excellent electrical and thermal conductivity, quick charge carrier mobility, large specific surface area, and good biocompatibility [11-14] and have thus been widely used in medical science and biotechnology, including in sensitive biosensors [15], drug delivery systems (DDSs) [16], and near-infrared (NIR) fluorescence imaging techniques [17-19].",
      "startOffset" : 263,
      "endOffset" : 270
    }, {
      "referenceID" : 11,
      "context" : "Graphite and its allotropes possess outstanding physicochemical properties, including high fracture strength and Young’s modulus, excellent electrical and thermal conductivity, quick charge carrier mobility, large specific surface area, and good biocompatibility [11-14] and have thus been widely used in medical science and biotechnology, including in sensitive biosensors [15], drug delivery systems (DDSs) [16], and near-infrared (NIR) fluorescence imaging techniques [17-19].",
      "startOffset" : 263,
      "endOffset" : 270
    }, {
      "referenceID" : 12,
      "context" : "Graphite and its allotropes possess outstanding physicochemical properties, including high fracture strength and Young’s modulus, excellent electrical and thermal conductivity, quick charge carrier mobility, large specific surface area, and good biocompatibility [11-14] and have thus been widely used in medical science and biotechnology, including in sensitive biosensors [15], drug delivery systems (DDSs) [16], and near-infrared (NIR) fluorescence imaging techniques [17-19].",
      "startOffset" : 263,
      "endOffset" : 270
    }, {
      "referenceID" : 13,
      "context" : "Graphite and its allotropes possess outstanding physicochemical properties, including high fracture strength and Young’s modulus, excellent electrical and thermal conductivity, quick charge carrier mobility, large specific surface area, and good biocompatibility [11-14] and have thus been widely used in medical science and biotechnology, including in sensitive biosensors [15], drug delivery systems (DDSs) [16], and near-infrared (NIR) fluorescence imaging techniques [17-19].",
      "startOffset" : 263,
      "endOffset" : 270
    }, {
      "referenceID" : 14,
      "context" : "Graphite and its allotropes possess outstanding physicochemical properties, including high fracture strength and Young’s modulus, excellent electrical and thermal conductivity, quick charge carrier mobility, large specific surface area, and good biocompatibility [11-14] and have thus been widely used in medical science and biotechnology, including in sensitive biosensors [15], drug delivery systems (DDSs) [16], and near-infrared (NIR) fluorescence imaging techniques [17-19].",
      "startOffset" : 374,
      "endOffset" : 378
    }, {
      "referenceID" : 15,
      "context" : "Graphite and its allotropes possess outstanding physicochemical properties, including high fracture strength and Young’s modulus, excellent electrical and thermal conductivity, quick charge carrier mobility, large specific surface area, and good biocompatibility [11-14] and have thus been widely used in medical science and biotechnology, including in sensitive biosensors [15], drug delivery systems (DDSs) [16], and near-infrared (NIR) fluorescence imaging techniques [17-19].",
      "startOffset" : 409,
      "endOffset" : 413
    }, {
      "referenceID" : 16,
      "context" : "Graphite and its allotropes possess outstanding physicochemical properties, including high fracture strength and Young’s modulus, excellent electrical and thermal conductivity, quick charge carrier mobility, large specific surface area, and good biocompatibility [11-14] and have thus been widely used in medical science and biotechnology, including in sensitive biosensors [15], drug delivery systems (DDSs) [16], and near-infrared (NIR) fluorescence imaging techniques [17-19].",
      "startOffset" : 471,
      "endOffset" : 478
    }, {
      "referenceID" : 17,
      "context" : "Graphite and its allotropes possess outstanding physicochemical properties, including high fracture strength and Young’s modulus, excellent electrical and thermal conductivity, quick charge carrier mobility, large specific surface area, and good biocompatibility [11-14] and have thus been widely used in medical science and biotechnology, including in sensitive biosensors [15], drug delivery systems (DDSs) [16], and near-infrared (NIR) fluorescence imaging techniques [17-19].",
      "startOffset" : 471,
      "endOffset" : 478
    }, {
      "referenceID" : 18,
      "context" : "The allotropes of carbon have various structures and properties but share a common two-dimensional (2-D) structure called graphene, which was first prepared in 2004 [20].",
      "startOffset" : 165,
      "endOffset" : 169
    }, {
      "referenceID" : 20,
      "context" : "2-D crystal of graphene is composed of six-atom rings in a honeycombed network with one-atom thickness; thus, graphene can function as a planar aromatic macromolecule [22], which results in several unique properties.",
      "startOffset" : 167,
      "endOffset" : 171
    }, {
      "referenceID" : 18,
      "context" : "Since a single layer of graphene was first prepared in 2004 using a sticky tape and a pencil [20], several efficient production methods for graphene have been developed, such as micromechanical exfoliation, chemical vapor deposition (CVD), epitaxial growth, and chemical synthesis [23].",
      "startOffset" : 93,
      "endOffset" : 97
    }, {
      "referenceID" : 21,
      "context" : "Since a single layer of graphene was first prepared in 2004 using a sticky tape and a pencil [20], several efficient production methods for graphene have been developed, such as micromechanical exfoliation, chemical vapor deposition (CVD), epitaxial growth, and chemical synthesis [23].",
      "startOffset" : 281,
      "endOffset" : 285
    }, {
      "referenceID" : 8,
      "context" : "In addition, GO can be mass produced with high throughput, low processing cost, and feasible chemical functionalization;[9] thus, graphene can be obtained in large quantities via the",
      "startOffset" : 120,
      "endOffset" : 123
    }, {
      "referenceID" : 23,
      "context" : "Compared with other carbon allotropes, such as CNTs, graphene has several advantages in various applications, including biosensors (including DNA [25], antibodies [26], saccharides [27], inorganic constituents [28], drug molecules [29, 30], and multicomponent [31] determination) and drug delivery, because of its lower toxicity and superior biocompatibility [32].",
      "startOffset" : 146,
      "endOffset" : 150
    }, {
      "referenceID" : 24,
      "context" : "Compared with other carbon allotropes, such as CNTs, graphene has several advantages in various applications, including biosensors (including DNA [25], antibodies [26], saccharides [27], inorganic constituents [28], drug molecules [29, 30], and multicomponent [31] determination) and drug delivery, because of its lower toxicity and superior biocompatibility [32].",
      "startOffset" : 163,
      "endOffset" : 167
    }, {
      "referenceID" : 25,
      "context" : "Compared with other carbon allotropes, such as CNTs, graphene has several advantages in various applications, including biosensors (including DNA [25], antibodies [26], saccharides [27], inorganic constituents [28], drug molecules [29, 30], and multicomponent [31] determination) and drug delivery, because of its lower toxicity and superior biocompatibility [32].",
      "startOffset" : 181,
      "endOffset" : 185
    }, {
      "referenceID" : 26,
      "context" : "Compared with other carbon allotropes, such as CNTs, graphene has several advantages in various applications, including biosensors (including DNA [25], antibodies [26], saccharides [27], inorganic constituents [28], drug molecules [29, 30], and multicomponent [31] determination) and drug delivery, because of its lower toxicity and superior biocompatibility [32].",
      "startOffset" : 210,
      "endOffset" : 214
    }, {
      "referenceID" : 27,
      "context" : "Compared with other carbon allotropes, such as CNTs, graphene has several advantages in various applications, including biosensors (including DNA [25], antibodies [26], saccharides [27], inorganic constituents [28], drug molecules [29, 30], and multicomponent [31] determination) and drug delivery, because of its lower toxicity and superior biocompatibility [32].",
      "startOffset" : 231,
      "endOffset" : 239
    }, {
      "referenceID" : 28,
      "context" : "Compared with other carbon allotropes, such as CNTs, graphene has several advantages in various applications, including biosensors (including DNA [25], antibodies [26], saccharides [27], inorganic constituents [28], drug molecules [29, 30], and multicomponent [31] determination) and drug delivery, because of its lower toxicity and superior biocompatibility [32].",
      "startOffset" : 231,
      "endOffset" : 239
    }, {
      "referenceID" : 29,
      "context" : "Compared with other carbon allotropes, such as CNTs, graphene has several advantages in various applications, including biosensors (including DNA [25], antibodies [26], saccharides [27], inorganic constituents [28], drug molecules [29, 30], and multicomponent [31] determination) and drug delivery, because of its lower toxicity and superior biocompatibility [32].",
      "startOffset" : 260,
      "endOffset" : 264
    }, {
      "referenceID" : 30,
      "context" : "Compared with other carbon allotropes, such as CNTs, graphene has several advantages in various applications, including biosensors (including DNA [25], antibodies [26], saccharides [27], inorganic constituents [28], drug molecules [29, 30], and multicomponent [31] determination) and drug delivery, because of its lower toxicity and superior biocompatibility [32].",
      "startOffset" : 359,
      "endOffset" : 363
    }, {
      "referenceID" : 31,
      "context" : "example, because of its high specific surface area [33], the drug loading ratio of graphene nanomaterials is considerably higher than those of other DDSs [34, 35].",
      "startOffset" : 51,
      "endOffset" : 55
    }, {
      "referenceID" : 32,
      "context" : "example, because of its high specific surface area [33], the drug loading ratio of graphene nanomaterials is considerably higher than those of other DDSs [34, 35].",
      "startOffset" : 154,
      "endOffset" : 162
    }, {
      "referenceID" : 33,
      "context" : "example, because of its high specific surface area [33], the drug loading ratio of graphene nanomaterials is considerably higher than those of other DDSs [34, 35].",
      "startOffset" : 154,
      "endOffset" : 162
    }, {
      "referenceID" : 34,
      "context" : "With the exist of GO, elastic modulus and tensile strength of nanofibers have been enhanced dramatically [36].",
      "startOffset" : 105,
      "endOffset" : 109
    }, {
      "referenceID" : 35,
      "context" : "first discovered that polyethylene glycol (PEG)-functionalized GO can be used as a novel drug nanocarrier to load anti-cancer drugs via non-covalent physisorption with in vitro cellular uptake capacity [37, 38].",
      "startOffset" : 202,
      "endOffset" : 210
    }, {
      "referenceID" : 36,
      "context" : "first discovered that polyethylene glycol (PEG)-functionalized GO can be used as a novel drug nanocarrier to load anti-cancer drugs via non-covalent physisorption with in vitro cellular uptake capacity [37, 38].",
      "startOffset" : 202,
      "endOffset" : 210
    }, {
      "referenceID" : 20,
      "context" : "As a basic component of other carbon allotropes, graphene has a 2-D structure composed of six-atom rings in a honeycomb network with one-atom thickness [22].",
      "startOffset" : 152,
      "endOffset" : 156
    }, {
      "referenceID" : 37,
      "context" : "Table 1 lists the physical properties of graphene [39].",
      "startOffset" : 50,
      "endOffset" : 54
    }, {
      "referenceID" : 40,
      "context" : "In general, the preparation methods can be classified into two categories: top-down organic synthetic approaches and bottom-up organic synthetic approaches [42].",
      "startOffset" : 156,
      "endOffset" : 160
    }, {
      "referenceID" : 18,
      "context" : "[20] first fabricated and observed single-layered graphene by exfoliating highly oriented pyrolytic graphite.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 42,
      "context" : "[47] developed an arc discharge method to fabricate graphene using hydrogen and helium as the buffer gas.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 43,
      "context" : "The most typical method is based on the cyclodehydrogenation of polyphenylene dendrimers [48].",
      "startOffset" : 89,
      "endOffset" : 93
    }, {
      "referenceID" : 44,
      "context" : "3 shows the synthesis of a PAH by cyclodehydrogenation [49].",
      "startOffset" : 55,
      "endOffset" : 59
    }, {
      "referenceID" : 45,
      "context" : "Ruoff and his group studied acetylenic coupling [50] and alkyne metathesis reactions [51, 52] with isomerization as another type of bottom-up organic synthesis.",
      "startOffset" : 48,
      "endOffset" : 52
    }, {
      "referenceID" : 46,
      "context" : "Ruoff and his group studied acetylenic coupling [50] and alkyne metathesis reactions [51, 52] with isomerization as another type of bottom-up organic synthesis.",
      "startOffset" : 85,
      "endOffset" : 93
    }, {
      "referenceID" : 47,
      "context" : "Ruoff and his group studied acetylenic coupling [50] and alkyne metathesis reactions [51, 52] with isomerization as another type of bottom-up organic synthesis.",
      "startOffset" : 85,
      "endOffset" : 93
    }, {
      "referenceID" : 49,
      "context" : "The earliest research on plasma-enhanced CVD was conducted in 2004 [54].",
      "startOffset" : 67,
      "endOffset" : 71
    }, {
      "referenceID" : 51,
      "context" : "GO has oxygen-containing hydrophilic groups on its surfaces as well as defects, but this compound still aggregates in the presence of salts because of the charge screening effect [57].",
      "startOffset" : 179,
      "endOffset" : 183
    }, {
      "referenceID" : 52,
      "context" : "To improve the deficiencies in the nature of graphene and GO, researchers usually introduce active functional groups that improve the dispersion in water and offer new optical, electric, and magnetic properties, among others [58].",
      "startOffset" : 225,
      "endOffset" : 229
    }, {
      "referenceID" : 53,
      "context" : "The main approach to the modification of graphene is through GO, the precursor of graphene; the abundant hydroxy, carboxyl, and epoxy groups can be used for covalent modifications, whereas the defects and edges have high reactivity [59, 60]; thus, these components can be used for the modification of graphene and GO.",
      "startOffset" : 232,
      "endOffset" : 240
    }, {
      "referenceID" : 54,
      "context" : "The main approach to the modification of graphene is through GO, the precursor of graphene; the abundant hydroxy, carboxyl, and epoxy groups can be used for covalent modifications, whereas the defects and edges have high reactivity [59, 60]; thus, these components can be used for the modification of graphene and GO.",
      "startOffset" : 232,
      "endOffset" : 240
    }, {
      "referenceID" : 55,
      "context" : "[61] first modified GO using a covalent method in 2006.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 59,
      "context" : "[65], also utilized the hydroxyl and carboxyl groups to modify GO.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 35,
      "context" : "Other polymers, such as PEG [37, 38, 67], poly(vinyl alcohol) (PVA) [68], polyethylenimine (PEI) [69], sodium alginate [70], and amphiphilic copolymers [71], have also been grafted onto graphene or GO sheets via covalent methods to improve their properties, such as increasing their stability, hydrophilicity, and cellular uptake or decreasing their cytotoxicity.",
      "startOffset" : 28,
      "endOffset" : 40
    }, {
      "referenceID" : 36,
      "context" : "Other polymers, such as PEG [37, 38, 67], poly(vinyl alcohol) (PVA) [68], polyethylenimine (PEI) [69], sodium alginate [70], and amphiphilic copolymers [71], have also been grafted onto graphene or GO sheets via covalent methods to improve their properties, such as increasing their stability, hydrophilicity, and cellular uptake or decreasing their cytotoxicity.",
      "startOffset" : 28,
      "endOffset" : 40
    }, {
      "referenceID" : 60,
      "context" : "Other polymers, such as PEG [37, 38, 67], poly(vinyl alcohol) (PVA) [68], polyethylenimine (PEI) [69], sodium alginate [70], and amphiphilic copolymers [71], have also been grafted onto graphene or GO sheets via covalent methods to improve their properties, such as increasing their stability, hydrophilicity, and cellular uptake or decreasing their cytotoxicity.",
      "startOffset" : 28,
      "endOffset" : 40
    }, {
      "referenceID" : 61,
      "context" : "Other polymers, such as PEG [37, 38, 67], poly(vinyl alcohol) (PVA) [68], polyethylenimine (PEI) [69], sodium alginate [70], and amphiphilic copolymers [71], have also been grafted onto graphene or GO sheets via covalent methods to improve their properties, such as increasing their stability, hydrophilicity, and cellular uptake or decreasing their cytotoxicity.",
      "startOffset" : 68,
      "endOffset" : 72
    }, {
      "referenceID" : 62,
      "context" : "Other polymers, such as PEG [37, 38, 67], poly(vinyl alcohol) (PVA) [68], polyethylenimine (PEI) [69], sodium alginate [70], and amphiphilic copolymers [71], have also been grafted onto graphene or GO sheets via covalent methods to improve their properties, such as increasing their stability, hydrophilicity, and cellular uptake or decreasing their cytotoxicity.",
      "startOffset" : 97,
      "endOffset" : 101
    }, {
      "referenceID" : 63,
      "context" : "Other polymers, such as PEG [37, 38, 67], poly(vinyl alcohol) (PVA) [68], polyethylenimine (PEI) [69], sodium alginate [70], and amphiphilic copolymers [71], have also been grafted onto graphene or GO sheets via covalent methods to improve their properties, such as increasing their stability, hydrophilicity, and cellular uptake or decreasing their cytotoxicity.",
      "startOffset" : 152,
      "endOffset" : 156
    }, {
      "referenceID" : 64,
      "context" : "energy release rate, and glass transition temperature were increased by 14%, 387%, and 13%, respectively [72].",
      "startOffset" : 105,
      "endOffset" : 109
    }, {
      "referenceID" : 65,
      "context" : "[73] exploited the solvent-free free radical grafting of styrene homopolymers and copolymers onto functionalized graphene nanosheets without the addition of an initiator.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 66,
      "context" : "[74] designed a simple, low-cost, and highly sensitive electrochemical sensor by utilizing a Nafion/ionic liquid/graphene composite-modified screen-printed carbon electrode.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 67,
      "context" : "[75] exploited a simple one-step reaction that simultaneously modifies and reduces GO.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 68,
      "context" : "[76], who utilized poly(sodium 4-styrenesulfonate) (PSS) to modify GO, which was reduced via exfoliation or in situ reduction.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 69,
      "context" : "[77] constructed a nanosupramolecular assembly through the non-covalent linkage of folic acid (FA)-modified β-cyclodextrin and GO with adamantane-grafted porphyrin via π–π ACCEPTED MANUSCRIPT",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 70,
      "context" : "[78] probed the potential adsorptive sites and molecular mechanisms",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 71,
      "context" : "[79] utilized π–π stacking interactions to load Au nanoparticles on GO.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 72,
      "context" : "[80] developed a new approach for graphene",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 74,
      "context" : "[82] have reported polymer–GO nanocomposites associated by hydrogen bonds.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 75,
      "context" : "In addition, van der Waals forces can be used in the non-covalent modification of graphene and GO [83].",
      "startOffset" : 98,
      "endOffset" : 102
    }, {
      "referenceID" : 76,
      "context" : "[84] compared the effectiveness of drugs loaded on PEI–GO that had been prepared using (a) a non-covalent adsorption method and (b) a covalent method and found that the carrier produced using method a was not as stable as that produced using method b.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 77,
      "context" : "[85] compared the antibacterial activity of graphite, graphite",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 78,
      "context" : "GO inhibited Gram-positive bacteria more effectively than Gram-negative bacteria [86], whereas some Gram-negative bacteria, such as E.",
      "startOffset" : 81,
      "endOffset" : 85
    }, {
      "referenceID" : 80,
      "context" : "coli and Gram-positive Bacillus subtilis [88].",
      "startOffset" : 41,
      "endOffset" : 45
    }, {
      "referenceID" : 82,
      "context" : "oryzae, a representative phytopathogenic bacteria that infects rice, was utilized to assess the antibacterial activity of RGO and GO; compared with RGO and the bactericide bismerthiazol, GO showed superior bactericidal effects because of its extremely sharp edges and generation of reactive oxygen species (ROS) [90].",
      "startOffset" : 312,
      "endOffset" : 316
    }, {
      "referenceID" : 83,
      "context" : "coli through hydrogen bonds between the lipopolysaccharides of the bacteria and the oxygen-containing functional groups of GO [91].",
      "startOffset" : 126,
      "endOffset" : 130
    }, {
      "referenceID" : 83,
      "context" : "Second, GO decreases the intake of nutrition from the surroundings while increasing the interaction between Ag and the bacteria [91].",
      "startOffset" : 128,
      "endOffset" : 132
    }, {
      "referenceID" : 85,
      "context" : "Ag can also disrupt the bacterial membrane, thereby inhibiting the respiration and replication of bacteria, which eventually leads to cell death [93].",
      "startOffset" : 145,
      "endOffset" : 149
    }, {
      "referenceID" : 84,
      "context" : "its antibacterial effect via a “capturing-killing process”, which increases the deposition of bacteria, as well as the contact between the cells and Ag-modified GO nanoparticles [92].",
      "startOffset" : 178,
      "endOffset" : 182
    }, {
      "referenceID" : 86,
      "context" : "[94] tested the antifungal activity of RGO using three fungal species (Aspergillus niger, Aspergillus oryzae, and Fusarium oxysporum).",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 87,
      "context" : "Nevertheless, some researches indicated GNFs coating materials can promote performance of some cell lines [95], several essential studies have investigated the cytotoxicity and apoptosis caused by GFNs in different cell lines.",
      "startOffset" : 106,
      "endOffset" : 110
    }, {
      "referenceID" : 88,
      "context" : "injury in PC12 cells in a dose- and shape-dependent manner [96] and caused plasma membrane damage in Hep G2 cells in a dose- and time-dependent manner [97], and RGO led to DNA fragmentation and chromosomal aberrations in human mesenchymal stem cells in a size- and concentration-dependent manner [98].",
      "startOffset" : 59,
      "endOffset" : 63
    }, {
      "referenceID" : 89,
      "context" : "injury in PC12 cells in a dose- and shape-dependent manner [96] and caused plasma membrane damage in Hep G2 cells in a dose- and time-dependent manner [97], and RGO led to DNA fragmentation and chromosomal aberrations in human mesenchymal stem cells in a size- and concentration-dependent manner [98].",
      "startOffset" : 151,
      "endOffset" : 155
    }, {
      "referenceID" : 90,
      "context" : "injury in PC12 cells in a dose- and shape-dependent manner [96] and caused plasma membrane damage in Hep G2 cells in a dose- and time-dependent manner [97], and RGO led to DNA fragmentation and chromosomal aberrations in human mesenchymal stem cells in a size- and concentration-dependent manner [98].",
      "startOffset" : 296,
      "endOffset" : 300
    }, {
      "referenceID" : 91,
      "context" : "[99] explored the biological effects of graphene in murine RAW 264.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 92,
      "context" : "[100] explored the blood compatibility of GFNs via the hemoglobin efflux from suspended red blood cells and investigated the cytotoxicity of GFNs via the mitochondrial activity of human skin fibroblasts in the water-soluble tetrazolium salt (WST-8) assay.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 93,
      "context" : "[101] evaluated the toxicity of graphene derivatives in contact with four cell lines (HeLa, MCF-7, SKBR3, and NIH3T3).",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 94,
      "context" : "Other studies have also reported the dose-dependent toxicity of GO and RGO on glioma cell lines [102], and GO caused",
      "startOffset" : 96,
      "endOffset" : 101
    }, {
      "referenceID" : 95,
      "context" : "dose-dependent membrane leakage and oxidative stress in ovarian cancer cells [103] and MCF-7 cells [104].",
      "startOffset" : 77,
      "endOffset" : 82
    }, {
      "referenceID" : 96,
      "context" : "dose-dependent membrane leakage and oxidative stress in ovarian cancer cells [103] and MCF-7 cells [104].",
      "startOffset" : 99,
      "endOffset" : 104
    }, {
      "referenceID" : 97,
      "context" : "The genotoxicity of graphene-based materials should be explored given the close correlation between DNA damage and mutation with cancer [105].",
      "startOffset" : 136,
      "endOffset" : 141
    }, {
      "referenceID" : 90,
      "context" : "[98] discovered that RGO nanoplatelets exerted genotoxic effects on human mesenchymal stem cells via DNA fragmentation ACCEPTED MANUSCRIPT",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 98,
      "context" : "[106] compared the genotoxicity of graphene-based biomaterials with those of SiO2, ZnO, TiO2, and Sn; each tested material had a dose-dependent genotoxic effect, but graphene caused the most serious DNA damage (1 μg mL -1 ).",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 99,
      "context" : "However, studies have shown that GO accumulates in certain organs, such as the lungs and liver, which can lead to potential toxicity [107].",
      "startOffset" : 133,
      "endOffset" : 138
    }, {
      "referenceID" : 75,
      "context" : "In vivo study Mice Direct injection Lungs Short-term Serious and persistent lung injury [83]",
      "startOffset" : 88,
      "endOffset" : 92
    }, {
      "referenceID" : 103,
      "context" : "Mice Intravenous injection Livers and spleens Long-term nontoxicity [111]",
      "startOffset" : 68,
      "endOffset" : 73
    }, {
      "referenceID" : 104,
      "context" : "Mice Intravenous injection Lungs, livers, and spleens Long-term acute injury and chronic inflammation [112]",
      "startOffset" : 102,
      "endOffset" : 107
    }, {
      "referenceID" : 106,
      "context" : "Zebrafish embryos Direct injection embryos Short-term Wide distribution without toxicity [114]",
      "startOffset" : 89,
      "endOffset" : 94
    }, {
      "referenceID" : 107,
      "context" : "Rabbit and rat Dripping Eyes Short-term Limited toxicity [115]",
      "startOffset" : 57,
      "endOffset" : 62
    }, {
      "referenceID" : 100,
      "context" : "Pulmonary edema, pulmonary thromboembolism, and granuloma formation [108-110] were observed in lungs in several in vivo studies.",
      "startOffset" : 68,
      "endOffset" : 77
    }, {
      "referenceID" : 101,
      "context" : "Pulmonary edema, pulmonary thromboembolism, and granuloma formation [108-110] were observed in lungs in several in vivo studies.",
      "startOffset" : 68,
      "endOffset" : 77
    }, {
      "referenceID" : 102,
      "context" : "Pulmonary edema, pulmonary thromboembolism, and granuloma formation [108-110] were observed in lungs in several in vivo studies.",
      "startOffset" : 68,
      "endOffset" : 77
    }, {
      "referenceID" : 75,
      "context" : "[83] administered graphene-based nanomaterials directly into the lungs of mice, where GO induced serious and persistent lung injury.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 103,
      "context" : "[111] explored the long-term in vivo biodistribution of PEGylated 125 I-labeled nanographene sheets; after ACCEPTED MANUSCRIPT",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 104,
      "context" : "[112] studied the long-term in vivo biodistribution of intravenously injected PSS-modified nano GO; the potential toxicity of the nanoparticles was systematically investigated for over six months.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 105,
      "context" : "The zebrafish, whose genome has close homology to the human genome, is one of crucial preclinical models for in vivo toxicity studies [113].",
      "startOffset" : 134,
      "endOffset" : 139
    }, {
      "referenceID" : 106,
      "context" : "[114] microinjected multi-functional graphene into zebrafish embryos; after a series of detections, significant abnormalities were not observed, and the zebrafish embryos’ survival rate was not affected, even though graphene was widely distributed in the zebrafish from head to tail.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 107,
      "context" : "[115] exposed GO to rabbits’ and rats’ eyes occasionally",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 108,
      "context" : "damages cellular macromolecules, such as proteins, DNA, and lipids [116]; the physical interaction between cells and graphene, which possesses sharp edges, causes cell membrane damage [117].",
      "startOffset" : 67,
      "endOffset" : 72
    }, {
      "referenceID" : 109,
      "context" : "damages cellular macromolecules, such as proteins, DNA, and lipids [116]; the physical interaction between cells and graphene, which possesses sharp edges, causes cell membrane damage [117].",
      "startOffset" : 184,
      "endOffset" : 189
    }, {
      "referenceID" : 108,
      "context" : "Given its hydrophobic surface, graphene can greatly affect cell membrane lipids and cause toxicity [116].",
      "startOffset" : 99,
      "endOffset" : 104
    }, {
      "referenceID" : 77,
      "context" : "In addition, its antibacterial activity may be attributed to the loss of membrane integrity [85].",
      "startOffset" : 92,
      "endOffset" : 96
    }, {
      "referenceID" : 110,
      "context" : "PEG, a non-toxic and non-immunogenic material approved by the United States Food and Drug Administration (FDA) for internal use in humans, has been widely used to modify GFNs [118].",
      "startOffset" : 175,
      "endOffset" : 180
    }, {
      "referenceID" : 103,
      "context" : "[111] coated ultra-small RGO with PEG through non-covalent modification before the nanoparticles were intravenously injected into mice at a dose of 20 mg kg -1 .",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 111,
      "context" : "In another study by this group, the toxicity of GO and PEGylated GO was compared after oral and intraperitoneal administration to mice at high doses [119].",
      "startOffset" : 149,
      "endOffset" : 154
    }, {
      "referenceID" : 61,
      "context" : "Other biocompatible materials, such as CS [66], PVA [68], PEI [69, 81], sodium alginate [70], β-cyclodextrin [77], and dextran [109] can also be used to modify GFNs using covalent and non-covalent approaches, as mentioned in “4.",
      "startOffset" : 52,
      "endOffset" : 56
    }, {
      "referenceID" : 62,
      "context" : "Other biocompatible materials, such as CS [66], PVA [68], PEI [69, 81], sodium alginate [70], β-cyclodextrin [77], and dextran [109] can also be used to modify GFNs using covalent and non-covalent approaches, as mentioned in “4.",
      "startOffset" : 62,
      "endOffset" : 70
    }, {
      "referenceID" : 73,
      "context" : "Other biocompatible materials, such as CS [66], PVA [68], PEI [69, 81], sodium alginate [70], β-cyclodextrin [77], and dextran [109] can also be used to modify GFNs using covalent and non-covalent approaches, as mentioned in “4.",
      "startOffset" : 62,
      "endOffset" : 70
    }, {
      "referenceID" : 69,
      "context" : "Other biocompatible materials, such as CS [66], PVA [68], PEI [69, 81], sodium alginate [70], β-cyclodextrin [77], and dextran [109] can also be used to modify GFNs using covalent and non-covalent approaches, as mentioned in “4.",
      "startOffset" : 109,
      "endOffset" : 113
    }, {
      "referenceID" : 101,
      "context" : "Other biocompatible materials, such as CS [66], PVA [68], PEI [69, 81], sodium alginate [70], β-cyclodextrin [77], and dextran [109] can also be used to modify GFNs using covalent and non-covalent approaches, as mentioned in “4.",
      "startOffset" : 127,
      "endOffset" : 132
    }, {
      "referenceID" : 36,
      "context" : "Since Dai and colleagues utilized PEGylated GO to deliver SN38, a camptothecin (CPT) analogue [38], graphene and GO have been extensively explored as novel drug carriers for drug delivery, including anti-cancer drugs, poorly soluble drugs, antibiotics, antibodies, peptides, and genes.",
      "startOffset" : 94,
      "endOffset" : 98
    }, {
      "referenceID" : 118,
      "context" : "Internal-Stimulatio n Targeting DOX RGO Non-covalent Van der Waals interaction UV, AFM, TEM MDA-MB-231 cells [126]",
      "startOffset" : 109,
      "endOffset" : 114
    }, {
      "referenceID" : 88,
      "context" : "DOX & CPT GO Covalent Carboxyl UV, FTIR, AFM, TEM MCF-7 cells [96]",
      "startOffset" : 62,
      "endOffset" : 66
    }, {
      "referenceID" : 119,
      "context" : "DOX GO Covalent Carboxyl FTIR, ZPD, TEM Hela cells [127]",
      "startOffset" : 51,
      "endOffset" : 56
    }, {
      "referenceID" : 120,
      "context" : "DOX GO Non-covalent Physical encapsulation UV, FTIR, AFM, NMR HepG2 cells male H22 hepatic tumor-bearing Kunming mice [128]",
      "startOffset" : 118,
      "endOffset" : 123
    }, {
      "referenceID" : 121,
      "context" : "DOX GQD Covalent Carboxyl UV, LSD, FTIR, TEM DU-145 cells, PC-3 cells [129]",
      "startOffset" : 70,
      "endOffset" : 75
    }, {
      "referenceID" : 123,
      "context" : "DOX GO Covalent Carboxyl UV, LSD, AMF C6 glioma cells C6 glioma-bearing Sprague−Dawley rat [131]",
      "startOffset" : 91,
      "endOffset" : 96
    }, {
      "referenceID" : 124,
      "context" : "Monoclonal antibody GO Covalent Carboxyl AFM, TEM, DLS MDA-MB-231 cells MDA-MB-231-bearing female nude mice [132]",
      "startOffset" : 108,
      "endOffset" : 113
    }, {
      "referenceID" : 125,
      "context" : "MTX G SEM, TEM, UV, AFM, XRD, Raman spectra, FTIR A549 cells [133]",
      "startOffset" : 61,
      "endOffset" : 66
    }, {
      "referenceID" : 126,
      "context" : "DOX G Covalent Carbon-carbon double bonds NMR, SEM, AFM, ATR-IR, TGA, UV [134]",
      "startOffset" : 73,
      "endOffset" : 78
    }, {
      "referenceID" : 127,
      "context" : "VB12 GO Non-covalent Physical encapsulation SEM, XRD [135]",
      "startOffset" : 53,
      "endOffset" : 58
    }, {
      "referenceID" : 128,
      "context" : "Fluorescein sodium RGO Covalent Hydroxyl UV, XRD, Raman spectra, XPS, AFM, TEM, SEM Hepatic stellate cells [136]",
      "startOffset" : 107,
      "endOffset" : 112
    }, {
      "referenceID" : 136,
      "context" : "External-Field Controlled Methyl orange RGO Non-covalent Hydrogen bonding SEM, UnC, ECC [144]",
      "startOffset" : 88,
      "endOffset" : 93
    }, {
      "referenceID" : 137,
      "context" : "Dexamethasone GO Non-covalent Electropolymerization EIS, AFM, SEM, FTIR, EA [145]",
      "startOffset" : 76,
      "endOffset" : 81
    }, {
      "referenceID" : 139,
      "context" : "RV RGO Non-covalent Hydrogen bonding AFM, UV, FTIR, Raman spectra 4T1 cells female 4T1 tumor-bearing BALB/c mice [147] ACCEPTED MANUSCRIPT",
      "startOffset" : 113,
      "endOffset" : 118
    }, {
      "referenceID" : 140,
      "context" : "20 Methylene blue GO Non-covalent Hydrogen bonding LSD, ZPD Hela cells male HeLa tumor-bearing athymic nude mice [148]",
      "startOffset" : 113,
      "endOffset" : 118
    }, {
      "referenceID" : 141,
      "context" : "DOX GO Covalent Carboxyl TEM, AFM, FTIR, SQID, AASA, TGA [149]",
      "startOffset" : 57,
      "endOffset" : 62
    }, {
      "referenceID" : 142,
      "context" : "DOX GO Covalent Oxygen-containing groups TEM, SEM, XRD, FTIR, XPS, Raman spectra, TGA, SQID, ZPD [150]",
      "startOffset" : 97,
      "endOffset" : 102
    }, {
      "referenceID" : 143,
      "context" : "Multifunctional DOX RGO Covalent Oxygen-containing groups TEM, XRD U251 glioma cells [151]",
      "startOffset" : 85,
      "endOffset" : 90
    }, {
      "referenceID" : 144,
      "context" : "DOX GO Covalent Carboxyl TEM, SQID, FTIR, UV Hela cells [152]",
      "startOffset" : 56,
      "endOffset" : 61
    }, {
      "referenceID" : 145,
      "context" : "DOX GQD Covalent Oxygen-containing groups UV, DLS, ZPD, XPS, Raman spectra, TEM Hela cells [153] ACCEPTED MANUSCRIPT",
      "startOffset" : 91,
      "endOffset" : 96
    }, {
      "referenceID" : 112,
      "context" : "internal-stimulation targeting DDS [120-124].",
      "startOffset" : 35,
      "endOffset" : 44
    }, {
      "referenceID" : 113,
      "context" : "internal-stimulation targeting DDS [120-124].",
      "startOffset" : 35,
      "endOffset" : 44
    }, {
      "referenceID" : 114,
      "context" : "internal-stimulation targeting DDS [120-124].",
      "startOffset" : 35,
      "endOffset" : 44
    }, {
      "referenceID" : 115,
      "context" : "internal-stimulation targeting DDS [120-124].",
      "startOffset" : 35,
      "endOffset" : 44
    }, {
      "referenceID" : 116,
      "context" : "internal-stimulation targeting DDS [120-124].",
      "startOffset" : 35,
      "endOffset" : 44
    }, {
      "referenceID" : 117,
      "context" : "Graphene/FA conjugates have shown high specificity and affinity for overexpressed FA receptors, which exist on the surface of cancer cells [125].",
      "startOffset" : 139,
      "endOffset" : 144
    }, {
      "referenceID" : 118,
      "context" : "[126] synthesized a novel anticancer drug carrier by conjugating RGO with FA via a completely non-covalent functionalization method.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 88,
      "context" : "[96] utilized the covalent approach to bind FA to NGO; sulfonic acid groups were used to maintain carrier stability in physiological solutions (Fig.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 119,
      "context" : "[127] utilized carboxymethyl CS and hyaluronic acid (HA) to modify GO via a covalent approach; the modified GO was used as a carrier to encapsulate the anticancer drug DOX.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 120,
      "context" : "[128] fabricated a novel HA−GO−DOX nanohybrid",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 122,
      "context" : "The peptides specifically bound to “αvβ3” integrins that were overexpressed on the surface of cancer cells [130].",
      "startOffset" : 107,
      "endOffset" : 112
    }, {
      "referenceID" : 123,
      "context" : "[131] to develop a glioma-targeting DDS; the Tf−PEG−GO−DOX DDS exhibited a 115.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 124,
      "context" : "[132] conjugated a monoclonal antibody, that acts against the follicle-stimulating hormone receptor (FSHR), with GO to fabricate an efficient cancer-targeting DDS.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 125,
      "context" : "[133] prepared gelatin-functionalized graphene nanosheets attached to methotrexate (MTX) to obtain pH-dependent release behavior; the release profile showed that the amount of drug released under acidic conditions was much higher than that under neutral conditions.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 126,
      "context" : "[134] designed a graphene/poly(acrylic acid) (PAA) hydrogel that was pH sensitive, mechanically strong, and thermally stable via reversible addition-fragmentation transfer (RAFT) polymerization; the controlled release profiles indicated that DOX was released more quickly at pH 7.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 127,
      "context" : "[135] utilized PVA to prepare a pH-sensitive GO composite hydrogel.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 128,
      "context" : "[136] reported a CS derivatives/RGO/ alginate hydrogel beads for small-molecule drug delivery.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 129,
      "context" : "This DDS strategy is called external-field-controlled DDS [137-143].",
      "startOffset" : 58,
      "endOffset" : 67
    }, {
      "referenceID" : 130,
      "context" : "This DDS strategy is called external-field-controlled DDS [137-143].",
      "startOffset" : 58,
      "endOffset" : 67
    }, {
      "referenceID" : 131,
      "context" : "This DDS strategy is called external-field-controlled DDS [137-143].",
      "startOffset" : 58,
      "endOffset" : 67
    }, {
      "referenceID" : 132,
      "context" : "This DDS strategy is called external-field-controlled DDS [137-143].",
      "startOffset" : 58,
      "endOffset" : 67
    }, {
      "referenceID" : 133,
      "context" : "This DDS strategy is called external-field-controlled DDS [137-143].",
      "startOffset" : 58,
      "endOffset" : 67
    }, {
      "referenceID" : 134,
      "context" : "This DDS strategy is called external-field-controlled DDS [137-143].",
      "startOffset" : 58,
      "endOffset" : 67
    }, {
      "referenceID" : 135,
      "context" : "This DDS strategy is called external-field-controlled DDS [137-143].",
      "startOffset" : 58,
      "endOffset" : 67
    }, {
      "referenceID" : 136,
      "context" : "[144] established a novel electroconductive hydrogel-based electrostimulated drug carrier.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 137,
      "context" : "[145] designed an electrically controlled drug delivery nanocomposite composed of GO deposited in a conducting polymer scaffold.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 139,
      "context" : "[147] designed an RGO/PEG composite as a photothermally controllable DDS.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 140,
      "context" : "[148] fabricated a GO-mediated delivery system through a non-covalent approach with a Pluronic block copolymer and methylene blue for combined photodynamic therapy and photothermal",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 141,
      "context" : "[149] first prepared a superparamagnetic GO-Fe3O4 hybrid through chemical precipitation.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 142,
      "context" : "[150] designed a cobalt ferrite/GO (CoFe2O4/GO) nanocomposite for magnetic resonance imaging (MRI) and controlled drug delivery.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 51,
      "context" : "27 single treatments that can target only one object is inadequate [57].",
      "startOffset" : 67,
      "endOffset" : 71
    }, {
      "referenceID" : 143,
      "context" : "[151] prepared a novel multifunctional DDS for the chemo-photothermal targeted therapy of gliomas.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 144,
      "context" : "[152] established a dual-target drug delivery and pH-sensitive controlled DDS based on multifunctional GO.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 145,
      "context" : "[153] reported novel hybrid SiO2-coated quantum dot (QD)-conjugated graphene for targeting cancer fluorescent imaging, tracking and monitoring of drug delivery, and ACCEPTED MANUSCRIPT",
      "startOffset" : 0,
      "endOffset" : 5
    } ],
    "year" : 2017,
    "abstractText" : "The discovery of graphene, a notable achievement in the field of novel carbon nanomaterials, has triggered the worldwide exploration of the biomedical applications of this material since 2004 because of its unique properties. The two-dimensional planar structure, large surface area, chemical stability, mechanical stability, and good biocompatibility of graphene are promising for applications in drug delivery systems (DDSs). In this review, we briefly discuss the characteristics, synthesis, and modification of graphene. We also investigate its toxicity and its applications in DDSs, with several representative examples. This review presents a comprehensive summary of graphene-based nanomaterials from their characteristics to their synthesis and applications, as well as their in vitro and in vivo evaluation in medicine. This paper provides a guiding strategy for the selection of optimal approaches to the fabrication of nanocarriers that are suitable for medical treatments and to ACCEPTED MANUSCRIPT",
    "creator" : null
  }
}